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Abstract
Male germ cell death plays an important role in spermatogenesis, during which the germ cells
(spermatogenic cells) are transformed from spermatogonia through spermatocytes and spermatids
into spermatozoa. The physiological apoptotic death process removes germ cells that are dysfunc-
tional or genetically damaged, or which do not fit the supportive capacity of somatic Sertoli cells.
Dysregulation of apoptosis, resulting either in the absence of appropriate germ cell death or in its
inappropriate occurrence, is associated with several testicular disorders, such as cryptorchidism,
infertility, or germ cell tumors. Thus, understanding of testicular physiology and pathology re-
quires knowledge about the control of germ cell death. Prior to the present studies, cell death in the
human testis was poorly characterized. Therefore, the aim was to create a model for investigating
human male germ cell death, and to study the regulation of germ cell apoptosis. Specific emphasis
was laid on the previously undetermined mechanisms related to mitochondrial functions, such as
oxidative events, adenosine triphosphate (ATP) production, and mitochondrial membrane perme-
ability transition.
In the present studies, an in vitro model was developed, in which segments of seminiferous tubules
(or pieces of testicular tissue) were cultured, rather than isolated cells, in order to maintain the
physiological cell-to-cell interactions which play an important role in the regulation of male germ
cell functions. The culture conditions, which included withdrawal of serum and hormones and
relative hyperoxia, rapidly (i.e. within 4 hours) induced testicular cell apoptosis. The apoptotic
germ cells were mainly spermatocytes and spermatids, but death of occasional spermatogonia was
also observed. Of the somatic cells, sporadic Leydig cells underwent apoptosis in the basic culture
conditions, whereas Sertoli cells appeared to be relatively resistant to induction of death. Other
types of cell death, including necrosis and cytotoxic morphological alterations, were triggered in
germ cells by exposure to toxic concentrations of hydrogen peroxide or potassium cyanide (KCN),
respectively.
The validity of the culture of seminiferous tubules to serve as a model of physiological stress
situations was supported by the ability of physiological testicular compounds, testosterone and
lactate, to prevent germ cell apoptosis. The thiol antioxidant N-acetyl-L-cysteine (NAC) and low
oxygen tensions also inhibited germ cell death, suggesting a role for oxidative conditions in the
regulation of germ cell apoptosis. In basic cultural conditions, a decrease in the testicular levels of
the adenine nucleotides (ANs) ATP, ADP, and AMP was observed concomitantly with progres-
sion of the apoptotic process in the germ cells. One of the potential explanations for the fall in ATP
is the permeability transition of the mitochondrial membrane (PT), which is followed by collapse of
the membrane potential and consequent cessation of ATP production by oxidative phosphoryla-
tion (OXPHOS). The involvement of PT in germ cell apoptosis was indicated by morphological
7alterations in the mitochondria of the dying cells, and by the abilities of two inhibitors of PT,
cyclosporin A (CsA) and N-methyl-Val4-Csa, to suppress germ cell apoptosis effectively. Factor(s)
related to mitochondrial ATP production appeared to be crucial regulators of germ cell death, since
(relative) hypoxia and chemical anoxia (KCN) inhibited cell death, whereas blockade of cytosolic
glycolysis had no effect on germ cell death. Unexpectedly, lactate, which is a physiological sub-
strate for the generation of male germ cell ATP, appeared not to affect the levels of ATP or other
ANs during culture. In the seminiferous tubules, the final site of the death-suppressing actions of
lactate, NAC, and KCN seemed to take place in germ cells downstream of activation of the death-
promoting Fas receptor.
In conclusion, by use of the present in vitro tissue culture model, mechanisms related to mitochon-
drial functions were shown to play important roles in the regulation of germ cell death in human
males. The findings are likely to have clinical implications, since some of the treatments used in the
present studies may be considered useful when treating certain patients with testicular disorders.
Abstract
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4. Abbreviations
∆Ψ
m
Mitochondrial membrane
potential
2-DG 2-deoxyglucose
ABP Androgen binding protein
ADP Adenosine diphosphate
AIF Apoptosis-inducing factor
AMP Adenosine monophosphate
AN Adenine nucleotide
ANT Adenine nucleotide
translocator
AP-1 Activating protein-1
Apaf-1 Apoptotic protease-activating
factor-1
AR Androgen receptor
ArKO Aromatase knockout
ATP Adenosine triphosphate
BMP Bone morphogenetic protein
BSA Bovine serum albumin
CsA Cyclosporin A
cyt c Cytochrome c
Dhh Desert Hedgehog
DHT Dihydrotestosterone
Dig-dd-UTP Digoxigenin-dideoxy-UTP
DNA Deoxyribonucleic acid
DR Death receptor
EC (Adenylate) energy charge
EM Electron microscopy
ER Endoplasmic reticulum
ER Estrogen receptor
ERαKO Estrogen receptor α knockout
F0F1 ATPase ATP synthetase
FAD Flavin adenine dinucleotide
(oxidized form)
FADH2 Flavin adenine dinucleotide(reduced form)
FasL Fas ligand
FSH Follicle stimulating hormone
GH Growth hormone
GnRH Gonadotropin-releasing
hormone
GPx Glutathione peroxidase
GSH Reduced glutathione
GSSG Oxidized glutathione
H2O2 Hydrogen peroxide
hCG Human chorionic
gonadotrophin
HPLC High performance liquid
chromatography
Hsp Heat shock protein
ICC Ischemic cell change
IGF-1 Insulin like growth factor 1
IM Mitochondrial inner membrane
ISEL In situ end labeling
IVF In vitro fertilization
KCN Potassium cyanide
LDH Lactate dehydrogenase
LH Luteinizing hormone
LIF Leukemia inhibitory factor
NAC N-acetyl-L-cysteine
NAD+ Nicotinamide adenine
dinucleotide (oxidized form)
NADH Nicotinamide adenine
dinucleotide (reduced form)
NADP+ Nicotinamide adenine
nucleotide phosphate (oxidized
form)
NADPH Nicotinamide adenine
nucleotide phosphate (reduced
form)
NF-κB Nuclear factor-κB
ΝMV-CsA N-methyl-Val4-CsA
O2- Superoxide anion
OH. Hydroxyl radical
OM Mitochondrial outer membrane
OXPHOS Oxidative phosphorylation
PBS Phosphate buffered saline
PCD Programmed cell death
PGC Primordial germ cells
Pi Orthophosphate
PPi Pyrophosphate
PRL Prolactin
PT Mitochondrial membrane
permeability transition
PTPC Permeability  transition  pore
complex
ROS Reactive oxygen species
rote Rotenone
SCF Stem cell factor
SMAC Second mitochondrial activator
of caspases
TNFR Tumor necrosis factor α
receptor
TNFα Tumor necrosis factor α
VDAC Voltage-dependent anion
channel
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Spermatogenesis is a complex developmental process by which male germ cells (spermatogenic
cells) are transformed from diploid spermatogonia via various phases through spermatocytes and
spermatids into highly specialized haploid spermatozoa (1-9). This process requires careful regu-
lation of germ cell proliferation, differentiation, self-renewal, and death. Germ cell death takes
place via apoptosis, which is also called programmed cell death, since it is an active, genetically
determined process, the induction and progression of which requires the temporal occurrence of
a set of biochemical and morphological changes (10-22). Apoptosis removes germ cells that are
dysfunctional or genetically damaged, or that do not fit the capacity of somatic Sertoli cells to
support the developing spermatogenic cells (5, 6, 23-27). Dysregulation of apoptosis, leading
either to the absence of appropriate germ cell death or to its inappropriate occurrence, has been
suggested to play a role in several testicular disorders (9, 24, 28-42). Thus, the understanding of
testicular physiology and pathology requires knowledge of how germ cell death is controlled. On
account of the possible species specificity of cellular responses, data on human testicular cell
death are preferred. However, prior to the present investigations, knowledge of male germ cell
apoptosis was based mainly on animal investigations. Therefore, the aim of the present studies
was to create a model for examining human male germ cell death and, with the help of that model,
to evaluate the regulation of germ cell apoptosis. Specific emphasis was laid on previously unde-
termined mechanisms related to mitochondrial functions, such as oxidative events, ATP produc-
tion, and mitochondrial permeability transition.
introduction
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6. Review of the Literature
6.1 SPERMATOGENESIS
6.1.1 The seminiferous tubules
Spermatogenesis takes place in the seminifer-
ous tubules of the testis (Fig. 1). The tubules
consist of the seminiferous epithelium, a tissue
composed of two basic cell types: the somatic
Sertoli cells and the germ cells (spermatogenic
cells) (1, 3, 7, 8, 43). In the adult testis, the Sertoli
cells are a population of non-proliferating cells
of a single type. Each Sertoli cell extends from
the basement membrane to the lumen. The germ
cells are a proliferating population composed of
cells at various levels of differentiation. The
most immature germ cells are located near the
basement membrane and the more mature germ
cells move toward the lumen of the seminiferous
tubule. Usually, four of five concentric layers of
germ cells can be identified within the seminifer-
ous epithelium. The seminiferous tubules are
surrounded by a basal lamina, which consists of
a basement membrane lying adjacent to seminif-
erous epithelium and of a lamina propria con-
taining contractile peritubular cells (myoid cells)
(1, 3, 7). The space surrounding the seminifer-
ous tubules is filled with interstitial tissue, which
contains blood vessels and lymphatic vessels,
nerves, loose connective tissue, and androgen-
secreting Leydig cells (1, 3, 7, 44).
6.1.2 Germ cell differentiation
Germ cell differentiation is initiated during the
embryonic period, when the primordial germ cells
(PGC) colonize the genital ridge. Under the in-
fluence of Sertoli cells, the PGC proliferate and
become gonocytes (23, 45). The gonocytes re-
main quiescent until after birth, when they are
reactivated and differentiate into spermatogo-
nia (23, 29). In the human, this differentiation
process takes place between birth and 6 months
of age (23, 29). In the prepubertal testis, occa-
sional spermatogonia may be transformed into
primary spermatocytes, but the majority of germ
cells undergo meiosis only after puberty (29,
46). Thus, during puberty there is progression
of germ cell development, which results in the
onset of mature (adult) spermatogenesis (23, 39).
During mature spermatogenesis, the germ cells
are transformed from spermatogonia via sev-
eral phases into highly specialized spermato-
zoa (1-9). The diploid spermatogonia, which re-
side in the basal compartment of the seminifer-
ous epithelium, proliferate by mitotic divisions,
giving rise to generations of cells that will pro-
ceed through spermatogenesis (2, 3, 5). For this
process to continue, the mitotic cells must also
perpetuate themselves, providing a population
of stem cells. Some of the stem cells, the “re-
serve” stem cells, divide at a low rate. If the
spermatogenic cells are destroyed, induction of
mitotic activity in the reserve stem cells can re-
establish the spermatogenic population. The
last mitotic division of spermatogonia gives rise
to early preleptotene spermatocytes, which ini-
tially reside in the basal compartment and re-
semble the spermatogonia in structure. They
soon migrate away from the basal lamina and
pass through the Sertoli-Sertoli junctional com-
plex (described below) into the adluminal com-
partment. The germ cells then increase in size
and demonstrate their distinctive nuclear mor-
phology as they pass through the leptotene,
zygotene, pachytene, and diplotene stages of
the meiotic prophase (2, 3, 7). The meiotic divi-
review of the literature
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Fig.1. Seminiferous tubules of the testis. A) Spermatogenesis takes place in the seminiferous
tubules of the testis. B) In the tubules, the male germ cells are organized into well-defined
cellular associations called stages, which  follow each other in a certain order and constitute
a cycle of the seminiferous epithelium. In humans, the cellular associations occur in irregu-
larly shaped areas along the tubule, and a cross-section through a tubule reveals two or more
distinct stages. In rodents, a particular stage occupies a relatively long segment along a
seminiferous tubule and a cross-section of a tubule typically includes only one stage. C) The
tubules contain seminiferous epithelium, which is composed of somatic Sertoli cells and
germ cells. Spermatogonia (s.gonia) are located near the basal lamina. As they are trans-
formed through spermatocytes (s.cyte) and spermatids (s.tid) into spermatozoa, they move
toward the lumen of the seminiferous tubule. The Sertoli cells, which are joined to each other
by unique junctional complexes, give structural and functional support to the developing
germ cells. [Modified from (50)].
review of the literature
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sions result in the production of haploid sper-
matids. These germ cells then undergo a
differentiative process called spermiogenesis,
during which the cells are transformed from early
(round) spermatids into spermatozoa. The ma-
jor features of this transformation include: (i)
formation of an acrosome; (ii) development of a
flagellum; (iii) condensation of chromatin, ac-
companied by changes in the shape and size of
the nucleus; and (ii) loss of excess cytoplasm.
Finally, through the process of spermiation, the
mature spermatozoon is released from the semi-
niferous epithelium into the lumen of the tubule
(2, 3, 7).
6.1.3 The Sertoli cell
The somatic Sertoli cells contain complex apical
and lateral processes that surround the adja-
cent germ cells and fill the spaces between them
(Fig.1). The Sertoli cells give structural organi-
zation to the seminiferous tubules as they ex-
tend through the full thickness of the seminifer-
ous epithelium and adjacent Sertoli cells are
joined to each other by unique junctional com-
plexes (1, 47, 48). The Sertoli-Sertoli junctional
complexes divide the seminiferous epithelium
into two compartments, i.e. a basal compartment
that contains spermatogonia and young sper-
matocytes, and an adluminal compartment that
contains later spermatocytes and spermatids (3,
44, 49).
The Sertoli cells play an essential role in the
development of the spermatogenic cells (2, 8, 9,
23, 47). Many of the Sertoli cell functions are
related to the compartmentalization of the semi-
niferous epithelium. By secreting fluids or re-
stricting the movements of molecules, the Ser-
toli cells establish microenvironments that are
indispensable for the development and differ-
entiation of the spermatogenic cells. Functions
ascribed to the Sertoli cells include: (i) provid-
ing physical (structural) support for the germ
cells; (ii) mediating the movements across the
seminiferous epithelium of the hormones, me-
tabolites, and nutrients utilized by the germ cells;
(iii) restricting the movements of extracellular
molecules into the seminiferous epithelium
through establishment of junctions between the
adjacent Sertoli cells; (iv) phagocytosing de-
generating spermatogenic cells and the excess
cytoplasm that is shed from the differentiating
spermatids as the residual bodies; (v) secreting
the various substances involved in the regula-
tion of testicular functions; and (vi) controlling
the movements of the spermatogenic cells
within the seminiferous epithelium and the re-
lease of the spermatozoa into the lumen of the
seminiferous tubule.
6.1.4 The cycle of the seminiferous
epithelium
The spermatogenic cells are not randomly dis-
tributed in the seminiferous epithelium, but are
organized into well-defined cellular associations
called stages (Fig. 1) (2-4, 6, 7, 47, 50-52). As a
consequence, in a particular developmental
phase, the same associations of cells are always
found together along the tubular wall. The
stages follow each other in a definitive order,
constituting the cycle of the seminiferous epi-
thelium. The number of stages (six in the hu-
man, and, for example, 12 in the mouse and mon-
key) and the duration of the full cycle (16 days
in the human) are constant for a given species
(1, 3, 4, 7, 50). It has been estimated that in hu-
mans it would require about 4.6 cycles, or ap-
proximately 74 days, for a spermatogonium pro-
review of the literature
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duced by a stem sell to complete the process of
spermatogenesis. In rodents, a particular stage
occupies a relatively long segment of a seminif-
erous tubule and a cross-section of a tubule
typically includes only one stage (Fig. 1). In
humans, the stages are oriented spirally, and a
cross-section through a tubule reveals two or
more distinct stages (Fig.1) (1, 3, 50, 52).
6.1.5 Hormonal control of spermato-
genesis
The cyclic hormonal control elicited by the hy-
pothalamic-pituitary unit is responsible for a
coordinated program of differentiation for the
germ cells. Gonadotropin-releasing hormone
(GnRH), produced by the hypothalamus, regu-
lates the release of the gonadotropins, i.e. lutein-
izing hormone (LH) and follicle-stimulating hor-
mone (FSH), from the pituitary gland (54). LH
receptors are known to be located on the Leydig
cells and FSH receptors on the Sertoli cells.
Therefore, it is widely believed that the germ
cells receive hormonal signals via the somatic
cells of the testis (8, 45, 54, 55). Stimulation of
Leydig cells by LH results in the secretion of
testosterone, and after puberty also of estro-
gens, into the interstitial compartment, from
which these hormones diffuse into the seminif-
erous tubules (53, 56). The Sertoli cells respond
to FSH and testosterone by secreting several
factors that can modulate spermatogenesis (9,
47, 55). In addition to its effects on Sertoli cells,
FSH may influence Leydig cell function by en-
hancing LH-stimulated secretion of testoster-
one (56). Direct effects of FSH on the germ cells
are not totally excluded either, since sporadic
studies have suggested that also germ cells ex-
press the FSH receptor (57). Interestingly, de-
spite the known action(s) of FSH in testicular
cells, there is evidence that FSH action per se is
not necessary for spermatogenesis (25, 58). In
addition to LH and FSH, the pituitary gland also
secretes prolactin (PRL) and growth hormone
(GH), which may play a role in testicular func-
tions, at least in some species (9, 25, 56).
Of the hormones produced locally in the testis,
testosterone has been shown to be indispens-
able for initiating and maintaining spermatoge-
nesis (3, 7, 56), but the targets of its action are
unclear. Androgen receptors (ARs) are ex-
pressed by the Sertoli cells (and Leydig and
myoid cells), which suggests that the effects of
testosterone on the germ cells are indirect and
are mediated by the Sertoli cells (8, 23, 59, 60).
However, sporadic studies claim the presence
of ARs in spermatogenic cells, suggesting that
testosterone has a direct action on them (61-
64). Furthermore, androgens can be aromatized
to estrogens, which, in turn, participate in the
regulation of spermatogenesis (7, 25). Inhibins
(specifically inhibin B), produced by the Sertoli
cells, have both endocrine and local effects on
spermatogenesis, whereas activins act only lo-
cally (3, 25). In addition, several autocrine and
paracrine factors, such as insulin-like growth
factor 1 (IGF-1), androgen binding protein (ABP)
and stem cell factor (SCF), participate in the regu-
lation of spermatogenesis (25, 53). Taken to-
gether, it appears that the various (hypotha-
lamic-) pituitary and testicular hormones and
factors synergize in the control of functional
spermatogenesis.
review of the literature
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6.2 ATP PRODUCTION
AND REACTIVE OXYGEN
SPECIES (ROS) IN THE
SEMINIFEROUS EPITHE-
LIUM
6.2.1 ATP production
The life and death of the cells in the seminifer-
ous tubules (as well as of other mammalian cells)
involve a complex, intricately regulated system
of energy-producing and energy-utilizing
chemical reactions. The essential linkage be-
tween these reactions is maintained by adenos-
ine 5´-triphosphate (ATP), a form of chemical
energy available to the cell (65-67). ATP is an
adenine (purine) nucleotide (AN) with three
energy-rich phosphoryl groups. Hydrolysis of
the phosphoryl group(s) liberates free energy
and converts ATP into adenosine 5´-diphos-
phate (ADP) and orthophosphate (Pi), or into
adenosine monophosphate (AMP) and pyro-
phosphate (PPi). The three ANs (ATP, ADP, and
AMP) are interconvertible through the follow-
ing reaction: 2 ADP  ATP+AMP (66). ATP in
the cells is formed either by glycolysis or by
oxidative phosphorylation (OXPHOS; mito-
chondrial respiration) (Fig. 2) (66-68). Both these
pathways include steps in which oxidation-re-
duction (redox) reactions play important roles
(66). These reactions are defined as reactions
involving the transfer of either only electrons
(e.g. between cytochromes) or both electrons
and protons (H+) [e.g. between nicotinamide
adenine dinucleotide (NADH) and flavin ad-
enine dinucleotide (FAD); NADH + H+ + FAD
NAD+ + FADH2] from a suitable electron do-
nor (the reductant) to a suitable electron accep-
tor (the oxidant).
6.2.1.1 Glycolysis
ATP production by the glycolytic pathway or
glycolysis takes place in the cytosol and does
not require oxygen (Fig. 2) (67, 68). In this ATP
generating pathway, glucose is converted, via
several steps, to pyruvate, which has several
possible metabolic fates (67, 68). First, it can be
oxidized by mitochondrial enzymes. Therefore,
glycolysis can be a preparatory pathway for
OXPHOS (described below). The end products
of glycolysis are pyruvate and NADH. In most
cells, the latter is reoxidized to NAD+ in aerobic
conditions by transfer of the reducing equiva-
lents of cytosolic NADH to mitochondria for
oxidation in the respiratory chain. In the ab-
sence of other NADH reoxidation systems, pyru-
vate can be reduced to lactate by an
oxidoreduction reaction catalyzed by lactate
dehydrogenase (LDH) with concomitant oxida-
tion of NADH to NAD+. In nontesticular cells,
LDH is confined to the cytosol so that the LDH
reaction is a metabolic dead end (68). In the pres-
ence of mitochondrial LDH, also lactate is a mi-
tochondrial substrate for mitochondrial oxida-
tive and energy-producing metabolism. Taken
together, glycolysis results in the generation of
ATP and pyruvate or lactate. To block the gly-
colytic pathway, several compounds can be
used, such as 2-deoxyglucose (2-DG), which
inhibits the very first step of glycolysis (Fig. 2)
(68).
6.2.1.2 Mitochondrial ATP production
A major portion of the energy-generating ca-
pacity of many cells resides in the mitochon-
dria, which exist in a variety of different shapes
depending upon the cell type. Mitochondria are
composed of two compartments: the matrix, sur-
rounded by the inner membrane (IM) and the
intermembrane space, surrounded by the outer
review of the literature
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Fig.2  ATP production and the glutathione cycle. A) ATP in the cells is formed either by glycolysis or by
oxidative phosphorylation (OXPHOS). Glycolysis takes place in the cytosol and does not require oxygen. In
the glycolytic pathway, ATP is produced while glucose is converted via several steps into pyruvate, which
can then be oxidized by mitochondrial enzymes or reduced to lactate (while NADH is oxidized to give NAD+)
by a reversible reaction catalyzed by lactate dehydrogenase (LDH). 2-deoxyglucose (2-DG) blocks glycolysis
by inhibiting its first step. Mitochondrial ATP production consists of reactions during which electrons are
released and via reducing equivalents (NADH and FADH2) passed to OXPHOS, which has two functional
components: the electron transport chain (respiratory chain) and ATP synthetase (F0F1 ATPase). B) The
electron transport chain of the inner mitochondrial membrane (IM) contains protein complexes I-IV, through
which the electrons, shuttled e.g. by cytochrome c (cyt c), pass sequentially to molecular oxygen. As the
electrons pass along the electron transport chain to lower energy levels, protons (H+) are pumped out from the
mitochondrial matrix side of the IM to the cytosolic side, which results in formation of a proton concentration
gradient and a membrane potential (∆ψm) across the inner mitochondrial membrane. These provide energy for
ATP synthesis when the protons return to the mitochondrial matrix side through the mitochondrial ATP
synthetase. Mitochondrial ATP generation can be suppressed e.g. by interrupting the supply of oxygen
(O2 ) or by inhibiting complex I by rotenone (rote) or complex IV by cyanide (e.g. potassium cyanide, KCN).
C) The glutathione cycle. Partial reduction of oxygen in OXPHOS results in formation of reactive oxygen
species (ROS). The glutathione (GSH) cycle is one of the antioxidative mechanisms controlling harmful
effects of ROS. During this cycle, the disposal of ROS is catalyzed by glutathione peroxidase. As a conse-
quence, the reduced form of glutathione (GSH) is converted to its oxidized form (GSSG), which is then
reduced back to GSH by GSSG reductase at the expense of reducing equivalents from NADPH.
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membrane (OM) (66, 67, 69). The outer mem-
brane is suggested to be a simple membrane,
whereas the highly invaginated inner membrane
is structurally and functionally much more com-
plex. The inner membrane has several transport
and enzymatic functions, such as most of those
attending mitochondrial energy production.
Mitochondrial ATP production consists of a
series of reactions involved in the tricarboxylic
acid cycle (citric acid cycle or Krebs cycle) and
OXPHOS (Fig. 2) (66, 67). The substrate of the
tricarboxylic acid cycle is acetyl coenzyme A,
which in turn can be formed, for example from
lactate or pyruvate (via reactions catalyzed by
LDH and pyruvate dehydrogenase), or from
metabolites of lipid degradation (66, 67). During
the reactions of the cycle, electrons are trans-
ferred to NAD+ and FAD. In their reduced forms
(NADH and FADH2), the reducing equivalents
enter the OXPHOS system. OXPHOS has two
functional domains: the electron transport chain
(the respiratory chain) and the ATP synthetase
(F0F1-ATPase, a proton-translocating ATPase)
(66, 67). The electron transport chain of the in-
ner mitochondrial membrane contains several
protein complexes (I-IV) through which the elec-
trons, shuttled, for-instance, by cytochromes
such as cytochrome c, pass sequentially to
molecular oxygen. As the electrons pass along
the electron transport chain to lower energy lev-
els, protons (H+) are pumped out from the mito-
chondrial matrix side of the inner membrane to
the cytosolic side of the membrane, which re-
sults in the formation of a proton concentration
gradient (∆pH) and a membrane potential (∆Ψ
m
)
across the inner mitochondrial membrane (66,
67, 69). These provide the energy for ATP syn-
thesis, during which the protons return to the
mitochondrial matrix side through the mitochon-
drial ATP synthetase. Mitochondrial ATP pro-
duction can be suppressed, for example, by in-
terrupting the supply of oxygen or by using
inhibitors of the complexes in the respiratory
chain, such as rotenone, which inhibits com-
plex I (NADH-ubiquinone oxidoreductase), or
cyanide, which binds to complex IV (cytochrome
c oxidase) and prevents oxygen from reacting
with it (66, 69).
6.2.2 ATP  production in the cells of
the seminiferous epithelium
The cells of the seminiferous epithelium differ
from each other with respect to the use of sub-
strates for ATP synthesis. Spermatogonia and
Sertoli cells exhibit high cytosolic glycolytic
activity (70). Spermatocytes and spermatids, in
turn, produce ATP mainly from lactate/pyruvate
by mitochondrial OXPHOS, whereas glycoly-
sis appears to be inefficient in maintaining their
ATP content, and no ATP is generated through
lipid degradation (70-75). Mature spermatozoa
differ from the developing germ cells in that they
are also able produce ATP from the fructose
obtained from semen, which is the only body
fluid containing free fructose (68).
Interestingly, it has been suggested that the
germ cells are able to utilize lactate directly by
way of their mitochondria, i.e. without prior cy-
tosolic oxidation to pyruvate, which is explained
by the presence of testis-specific LDHs (LDHc,
LDH-C4, LDH-X) (43, 45, 72, 76-80). In contrast
to the cytosolic nontesticular LDH, these en-
zymes of spermatocytes, spermatids, and sper-
matozoa are found not only in the cytosol, but
also in the mitochondria. In aerobic conditions,
the end products of cytosolic glycolysis in non-
testicular cells are usually pyruvate and NADH.
In these cells, the reoxidation of cytosolic NADH
takes place in the mitochondria, where, despite
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the impermeability of the mitochondrial mem-
brane to NADH (and NAD+), it can occur due to
several shuttle mechanisms. Should the mito-
chondrial reoxidation of NADH be unsuccess-
ful or impossible, NAD+ is regenerated using
the oxidizing power of pyvuvate, which in turn
is reduced to lactate, resulting in a metabolic
dead end if there is no mitochondrial LDH. Thus,
the mitochondrial LDH of germ cells enables
pyruvate to be utilized for reoxidation of NADH,
and this can also occur in aerobic conditions
(68). In other words, the mitochondria of the
germ cells are able to oxidize the lactate obtained
from glycolysis (or, in spermatozoa, from
fructolysis), making the shuttle systems (which
also exist in the germ cells) for the transport of
reducing equivalents into mitochondria unnec-
essary (68). The mitochondrial metabolism of
lactate results in the conversion of NAD+ to
NADH within these organelles, and makes the
reducing power of NADH directly available to
the electron transfer system and the ATP syn-
thesis (72). Therefore, in the germ cells, lactate
has been suggested to be the preferred sub-
strate for ATP synthesis. This view is supported
by the high levels of lactate and low levels of
glucose and pyruvate in the fluid of seminifer-
ous tubules (81). On the other hand, it has been
proposed that a high intratubular concentration
of lactate is required for the use of endogenous
pyruvate as the predominant energy-yielding
substrate by spermatocytes and spermatids (71).
Nevertheless, the lactate utilized by these germ
cells is derived from the somatic Sertoli cells, in
which a large amount of the glucose is metabo-
lized to lactate (71-74, 82). Thus, in testicular
energy metabolism, different cell types use di-
verse pathways for ATP production, and the
cellular interactions between the Sertoli cells and
the germ cells appear to play an important role.
6.2.3 ROS and the antioxidative
systems
The term ROS refer to oxygen-containing free
radicals, such as the superoxide anion (O2-) and
the hydroxyl radical (OH.) and some related non-
radical compounds which have the ability to
generate more ROS (such as H2O2). Any atom
or molecule containing one or more unpaired
electrons is a free radical. Free radicals are highly
reactive on account of their tendency to gain
electron(s) from another molecule, which is then
oxidized and, in turn, becomes a radical (83, 84).
ROS are generated during the physiological
metabolism of all aerobic cells and during sev-
eral pathological conditions (85-87). The main
sources of ROS are the reactions of OXPHOS,
in which partial reduction of oxygen may result
in ROS formation (83, 87, 88). The production of
ROS is correlated with the concentration of free
oxygen, and consequently consumption of oxy-
gen appears to decrease their generation (89,
90). The target molecules with which the ROS
have the ability to react include all the principal
components of the cell, such as nucleic acids,
proteins, carbohydrates and lipids (87, 91). ROS
have many beneficial functions since they par-
ticipate in cellular signaling, in the regulation of
cell growth, proliferation and differentiation, in
defense mechanisms against micro-organisms,
or in the capacitation process (88, 92-95). How-
ever, many of the effects of ROS action are de-
structive and harmful, and a situation in which
their levels are inappropriately high is known
as oxidative stress (87). The cell controls the
harmful effects of ROS through a protective
network referred to as the antioxidant defense,
which includes antioxidative enzymes, non-en-
zymatic antioxidant molecules, and enzymes re-
versing the cellular damage induced by oxidants
(87, 88). This defense system inhibits ROS for-
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mation, scavenges ROS and/or repairs the dam-
age caused by ROS.
One important cellular antioxidant defense
mechanism is the glutathione cycle (Fig. 2C) (87,
88, 96). During this cycle, disposal of ROS is
catalyzed by glutathione peroxidase (GPx). As
a consequence, the reduced form of glutathione
(thiol, GSH) is converted into its oxidized form
(disulfide, GSSG), which is then reduced back
to GSH by GSSG reductase at the expense of
reducing equivalents from NADPH (Fig. 2). A
decrease in the concentration of total GSH to-
gether with a lowered GSH/GSSG ratio is con-
sidered to reflect oxidative stress (87, 97-99).
Most of cellular GSH is located in the cytosol,
but mitochondria appear to have a distinct pool
of GSH and the GSH-dependent reactions are
thought to be one of the main mechanisms by
which mitochondria dispose of ROS (97). In
addition to serving as a cosubstrate for GPx,
GSH has several other important functions, such
as direct radical scavenging, conjugation reac-
tions, and maintenance of the thiol status of
proteins (97, 98, 100). N-acetyl-L-cysteine (NAC)
is a well-established thiol antioxidant that can
effectively increase intracellular GSH levels (88,
101, 102). After cellular uptake, this synthetic
peptide is deacetylated and converted into glu-
tathione (101, 102). NAC also has direct
antioxidative and various other effects on cells
(101, 103). Furthermore, in several systems it is
an effective inhibitor of cell death (88, 103-105).
6.2.4 ROS and antioxidative system
in the cells of the seminiferous
tubules
In the seminiferous tubules, ROS are continu-
ously produced by the Sertoli cells and the germ
cells as a result of their incessant metabolic ac-
tivity and the dynamic developmental process,
respectively. Furthermore, ROS production takes
place during normal steroidogenesis, for ex-
ample, in the Leydig cells (106, 107). The differ-
ent testicular cells are believed to display a
highly variable susceptibility to oxidative stress
(108). The differentiating germ cells are more
vulnerable targets for ROS than the somatic
cells. This is explained by the fact that, during
the maturation process, germ-line DNA is con-
densed and its repair functions are lost, which
makes the DNA a potential target for ROS ac-
tion (109). Moreover, the testicular cells are rich
in polyunsaturated lipids, which are sensitive
to the action of ROS (110). In order to prevent
the harmful effects of ROS, the testicular cells
contain antioxidant systems. The profiles of
these systems vary among different cell types
(108, 111, 112). Regarding the glutathione sys-
tem, the somatic Sertoli cells and peritubular cells
have high GSH-dependent enzyme activities
associated with high GSH contents. Spermato-
cytes and spermatids, in turn, present a differ-
ent system characterized by a higher GSH con-
tent and a very low GSH-dependent enzyme
activity. Spermatozoa exhibit the same enzy-
matic system as spermatocytes and spermatids,
but are devoid of GSH. Interstitial tissue, in turn,
displays a high GSH content and moderate ac-
tivities of GSH-related enzymes, except for el-
evated GPx (108).
ROS and steroid hormones. Interestingly, there
are associations between oxidative mechanisms
and steroid hormones (table 1). ROS produc-
tion has been suggested to control steroido-
genesis (106, 113), whereas steroidogenesis has
been proposed to increase ROS production
(106). Steroid hormones, in turn, have been
shown to regulate antioxidant mechanisms, for
example, in testicular and ovarian cells (89, 111,
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114-118). Furthermore, some steroid hormones,
such as testosterone, androstendione, and es-
trogens, have been shown to act as antioxidants
or to prevent ROS formation (118-121). How-
ever, there are also opposite findings, such as a
testosterone mediated increase in lipid
peroxidation levels, suggesting induction of
oxidative stress, and a decrease in the levels of
certain antioxidative enzymes, including GPx
(114). Thus, the oxidative functions and steroid
hormones are clearly interrelated, but the mecha-
nisms underlying their interactions have re-
mained unclear.
6.3 MALE GERM CELL
DEATH
6.3.1 Cell death
The development, maintenance, and function
of the tissues and organs, such as of the testis,
require a balance between cellular proliferation
and death (11, 18, 23, 24). Whether a cell sur-
vives or dies is determined by a complicated
network of signals. The cells respond to exter-
nal signals and to their internal milieu by acti-
vating signaling mechanisms that ultimately
determine their fate (23, 122). In general, there
appear to be distinct modes of cell death: i)
apoptosis or programmed cell death (PCD), ii)
autophagocytic cell death, iii) necrosis, and iv)
necrapoptosis.
6.3.1.1 Apoptosis or programmed
cell death (PCD)
Apoptosis is also called programmed cell death,
since it is an active, genetically determined pro-
cess, the induction and progression of which
requires the temporal occurrence of a set of bio-
chemical and morphological changes (10-22). It
is a physiological cellular process of self-de-
struction, which presumably developed because
it conferred an evolutionary advantage to the
organism. Thus, it removes cells that are un-
wanted, senescent, or genetically damaged,
whose continued existence poses harm or dan-
ger to the host. The word apoptosis comes from
the Greek language, in which it is used to de-
scribe falling of petals from flowers or leaves
from trees (21). Apoptotic cells exhibit several
typical features, including cell membrane dis-
ruption, cytoskeletal rearrangement, nuclear
condensation, and internucleosomal DNA frag-
mentation into ca185 base pair multiples (10, 12,
19, 21, 22, 24). In addition to its beneficial ef-
fects, apoptosis accounts for cell death occur-
ring under a variety of pathological circum-
stances (11, 19, 123, 124).
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The internal cell death machinery for carrying
out apoptosis appears to be constitutively
present in most mammalian cells, but activation
of the death program is regulated by variety of
signals that originate from both the intracellular
and extracellular milieu (18, 22, 123, 125). Inter-
estingly, parts of the internal cascades of
apoptosis are highly conserved, whereas other
parts vary notably, depending on the cell type
and the inducer of PCD. Despite the differences
in the pathways of cell death, the events of
apoptosis can be broken down into the follow-
ing phases (Fig. 3).
The initiation phase (triggering and early intra-
cellular signaling) of apoptosis. During the ini-
tiation phase, the apoptotic cascades are acti-
vated (69, 124, 126). The cell receives a poten-
tially lethal stimulus, which may take many
forms (124). Apoptosis can be triggered, for ex-
ample, by changes in the levels of hormones,
auto- or paracrine factors; or by active induc-
tion via exposure to death-promoting signals,
such as the cytokines Fas ligand (FasL, CD95
ligand, APO-1 ligand) or tumor necrosis factor
α (TNFα) (14, 124, 126). Activation of apoptosis
results in the recruitment of early intracellular
signaling molecules that relay the incoming in-
formation for interpretation (Fig. 3) (22, 124, 126-
129). The messengers utilized in the apoptotic
cascades by each cell vary, depending upon
the type and magnitude (dose and duration) of
the stimulus received, and include molecules
derived from both gene expression and cellular
metabolism (124).
The decision or effector phase of apoptosis.
The decision or effector phase of apoptosis in-
cludes integration of the information provided
by signals from the initiation phase into a final
decision for cellular life or death. In some cell
types and as a result of certain inducers of
apoptosis, this phase is independent of mito-
chondrial events (Fig. 3) (14, 15, 130). In numer-
ous other cell types and with various triggers
of PCD, this phase takes place at the level of the
mitochondria, which then constitute the center
of death control (Fig. 3) (17, 69, 124, 126, 127,
130-134). In certain cell types and situations,
the non-mitochondrial and mitochondrial events
of this phase may be linked (14).
The executioner or degradation phase of
apoptosis. This third and final phase of
apoptosis involves the ”executioner” mol-
ecules. In mitochondria-dependent pathways,
proteins released from the mitochondria acti-
vate the execution cascades of apoptosis (14,
69, 127). In mitochondria-independent path-
ways, these cascades are activated via alterna-
tive routes (14, 22). All pathways lead to the
action of proteases and nucleases (Fig. 3),
which are responsible for such degradation pro-
cesses as cleavage of chromatin into DNA frag-
ments of internucleosome length (ca 185 base
pairs) (20-22, 24, 135). This DNA fragmentation
results from apparently random double-stranded
DNA breaks in the linker regions between the
nucleosomal cores and can be detected as a
ladder pattern on agarose gel electrophoresis.
It is of note that, although internucleosomal
DNA fragmentation has been considered a hall-
mark of apoptosis, cleavage of DNA by endo-
nucleases does not appear to be constant fea-
ture of apoptosis (20, 22, 135).
6.3.1.2 Autophagocytotic cell death
Autophagocytosis is a mechanism of protein
turnover continuously taking place in most cells.
It involves the formation of autophagosomes,
which are fusion products of lysosomes with
review of the literature
22
Fig. 3. Different phases of apoptosis. During the initiation phase (triggering and early intracellular signaling),
apoptotic cascades are triggered by various inducers, such as withdrawal of hormones or activation of death
receptors by their ligands, e.g FasL or TNFα. This triggering results in recruitment of early intracellular
signaling molecules, e.g. caspase 8, which relay the information for interpretation, which, in turn, takes place
during the effector (decision) phase. This phase can take place either independently of or dependently on
mitochondrial control. The mitochondrial pathways induce mitochondrial membrane permeability transition
(PT), followed by release of proteins, such as cytochrome c (cyt c) and the apoptosis-inducing factor (AIF),
into the cytosol, and dissipation of the membrane potential (∆ψm). The loss of ∆ψm together with cyt c
depletion from the mitochondria are thought to result in disruption of OXPHOS, with a consequent drop in
ATP production. Many anti- and pro-apoptotic factors, such as the Bcl-2 family members, p53 and ceramide,
act (at least partly) at the level of mitochondria. Furthermore, reactive oxygen species (ROS) produced by
mitochondria have been associated with apoptotic events. The third and final phase of apoptosis (the
executioner or degradation phase) involves action of the executioner molecules, such as proteases and nu-
cleases. In mitochondria-dependent pathways, the proteins released from mitochondria activate the execution
cascades of apoptosis, e.g. cyt c binds to Apaf-1 (apoptotic protease-activating factor-1) and thereafter
procaspase-9, which leads to activation of downstream effectors. In mitochondria-independent pathways,
these cascades are activated via alternative routes. The executioner proteases and nucleases are responsible for
the degradation processes, such as DNA fragmentation, i.e. cleavage of chromatin into apoptotic
internucleosome-length DNA fragments (ca 185 base pairs).
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mono- or multilayered lipid membrane vesicles
enclosing regions of cytoplasm which usually
include organelles (13). In addition to maintain-
ing protein homeostasis during normal cellular
functions, activation of autophagocytosis may
result in cell death (13). Indeed, when activated
well beyond the normal rate, it is capable of be-
ing a principal dispenser of death to cells. Thus,
autophagocytotic cell death resembles
apoptosis in that it involves the formation of
new structures and stereotyped progress of cell
death (13).
6.3.1.3 Necrosis
Necrosis, or necrotic cell death, is an acciden-
tal, passive, and non-programmed process which
results in progressive and irreversible break-
down of ordered cell structure and function (19,
136). It is considered to be morphologically and
biochemically distinct from apoptosis (13, 16,
18, 20, 21, 125, 136). It occurs in response to an
overwhelming insult, and does not appear to
require gene expression or elaboration of new
structures as part of the process. Necrosis is
usually accompanied by rapid collapse of inter-
nal cell homeostasis. It is characterized by swell-
ing of cells, early loss of plasma membrane in-
tegrity, major changes to the organelles, and
swelling of the nucleus with flocculation of the
chromatin. Necrotic events ultimately lead to
dissolution of the organelles and rupture of the
plasma membranes, allowing the cellular con-
tents to spill into the surrounding tissue space,
where they evoke an inflammatory response (18,
21, 136). In necrosis, DNA degradation, if
present, is a late phenomenon and the chroma-
tin is digested by proteases and endonucleases
into a smear pattern instead of the ladder pat-
tern seen in apoptosis, because the proteases
destroy the histones and expose the entire
length of DNA to nucleases (21). Necrotic cell
death can be divided into three types; i) edema-
tous or pale cell change, ii) ischemic cell change
(ICC), and iii) homogenizing cell change/ghost
cells, which is often assumed to follow from ICC
(13). By far the most common of these is the
ischemic/homogenizing cell change, in which
the cell first shrinks dramatically and becomes
very electron-dense. A less common is edema-
tous cell change, involving swelling of the cell
and disruption of the structure of the organelles
(13).
6.3.1.4 Necrapoptosis
It is not completely known why a particular
mode of death occurs in a given cell as a result
of a particular insult. However, it is apparent
that one insult can give rise to more than one
mode of death in the same population of cells
and that a certain cell may manifest signs of
more than one mode of death (13, 136). Interest-
ingly, the final stages of apoptosis may be very
similar to those of necrotic cell death (13, 136).
The term necrapoptosis has been introduced to
cover events of this kind (136). Necrapoptosis
means a process that begins with the common
death signal or stress effect, but that culminates
in either cell lysis (necrosis) or programmed cel-
lular resorption (apoptosis), depending on other
modifying factors (136). Pure apoptosis and
pure necrosis have been suggested to repre-
sent extremes in the spectrum of necrapoptotic
responses, but the more typical response of tis-
sues and cells to death signals have been pro-
posed to be a mixture of the events associated
with apoptotic and necrotic cell death (136).
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6.3.2 Male germ cell death
Apoptotic death of male germ cells takes place
under physiological and various non-physi-
ological conditions (23, 25). Germ cell necrosis,
in turn, appears to be induced as a consequence
of severe insults, such as serious ischemia-
reperfusion injuries or exposure to certain toxic
agents (25, 137, 138) .
6.3.2.1 Physiological germ cell
apoptosis
During the first round or wave of spermatogen-
esis, the initial cohort of germ cells differenti-
ates into more mature germ cell types, i.e. sper-
matocytes and spermatids, and finally into sper-
matozoa. This first wave of spermatogenesis
(usually completed by the time of puberty) in-
volves extensive germ cell apoptosis, which is
required for the development of functional sper-
matogenesis (23, 39, 139, 140). During normal
adult (mature) spermatogenesis, germ cell death
is also conspicuous (5, 6, 23-27). It has been
estimated, that due to this spontaneous
apoptosis, the seminiferous epithelium yields
up to 75% fewer spermatozoa than would be
anticipated from spermatogonial proliferations
(23, 24, 141, 142). However, the exact incidence
of adult male germ cell apoptosis remains un-
clear, since not all of the degenerating germ cells
display the classical morphology of apoptosis.
Dying spermatogonia and round spermatids
exhibit many of the classical morphological and
biochemical features of apoptosis, but the death
of spermatocytes and elongated spermatids is
not unequivocal. These cells do not show the
characteristic nuclear changes usually associ-
ated with apoptosis, possibly because of the
unusual morphology and configuration of their
DNA (23, 143, 144). Furthermore, the death of
spermatozoa, which have little cytoplasm, is
poorly characterized and possibly does not in-
volve the classical apoptotic machinery, since,
for example, caspases (described below) do not
appear to be involved (23). Spontaneous germ
cell apoptosis probably occurs for various rea-
sons, most of which are still unknown. It has
been suggested that the early wave of apoptotic
germ cells is required to reduce the number of
differentiating spermatogonia to fit the capac-
ity of the Sertoli cells to support the developing
germ cells (23, 39, 139). In mature spermatogen-
esis, one of the targets of germ cell apoptosis is
proposed to be selective removal of dysfunc-
tional or damaged germ cells. Spermatocytes
unable to complete meiosis appear to be de-
leted by apoptosis (23). By this elimination of
damaged germ cells, transmission of genetic
abnormalities to offspring can be prevented.
6.3.2.2 Inappropriate death of male
germ cells
Dysregulation of apoptosis, leading either to
the absence of appropriate germ cell death or to
its inappropriate occurrence, has been sug-
gested to play a role in several situations con-
cerning testicular pathology. These situations
are detailed below in the paragraph “Clinical
implications”. Furthermore, various external dis-
turbances, such as alterations in hormonal sup-
port, elevated temperature, ischemia, or expo-
sure to  toxicants, to radiation, or to chemo-
therapeutic compounds, may result in excessive
germ cell death (5, 145-150).
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6.3.3 Regulation of apoptosis
6.3.3.1 Extracellular regulation of
male germ cell apoptosis
The external signals involved in determining the
fate of male germ cells include direct cell con-
tact, auto- or paracrine, and endocrine signals,
which are derived from the Sertoli cells with
which each germ cell is closely associated, or
possibly from other germ cells, or from outside
the testis (23, 122) .
Direct cell contact and auto- or paracrine sig-
nals. Direct cell contact signals are signals de-
rived from the Sertoli cells by direct membrane
contact, and possibly also from adjacent germ
cells. The Sertoli cells provide nutrition, adhe-
sion, and several transport functions, which play
an important role in the survival and differentia-
tion of the germ cells (23). In addition, several
locally produced auto- or paracrine proteins
such as stem cell factor (SCF), Fas ligand (FasL),
tumor necrosis factor α (TNFα), leukemia in-
hibitory factor (LIF), interleukin-4, members of
the bone morphogenetic protein (BMP) family
and Desert Hedgehog protein (Dhh) have been
suggested to participate in regulation of the fate
of germ cells (23, 122, 151). The paracrine (and
endocrine) hormonal signals contributing to
male germ cell survival are described in the fol-
lowing paragraph. The exact mechanisms by
which direct cell contact and auto- or paracrine
signals, and probably their synergy, determine
the fate of germ cells, are unclear.
Hormonal control of germ cell apoptosis. Gona-
dotropins, i.e. LH or human chorionic gonadot-
ropin (hCG) and FSH, as well as androgens, are
known to influence male germ cell death (3, 23,
24, 27, 56, 148, 152). Decreases in the levels of
gonadotropins and/or androgens, or inhibition
of their action, induces apoptotic degeneration
of male germ cells (148, 152-159). Accordingly,
the pro-survival action of these hormones is
indicated by prevention of germ cell apoptosis
by hCG, FSH, or testosterone (148, 155, 156, 160).
However, their anti-apoptotic role is not un-
equivocal and there have been opposing find-
ings. Thus, testosterone appears to be pro-
apoptotic at one of the stages of the spermato-
genic cycle (stage XII, rats in vitro) (155), and
hCG, when administered to prepubertal boys
with undescended testes, increases germ cell
apoptosis (28). In addition to gonadotropins and
androgens, prolactin (PRL) has been suggested
to regulate apoptosis in the testis, since elevated
levels of PRL induced germ cell death, which
was suppressed by antiserum against PRL (161,
162). Furthermore, estrogens are now consid-
ered to be potential controllers of male germ cell
death (7, 163). Thus, mice lacking the estrogen
receptor alpha (ERαKO) are infertile because of
impaired fluid reabsorption in the efferent
ductules and resultant pressure-induced atro-
phy of the seminiferous epithelium (164, 165).
Moreover, aromatase knockout (ArKO) mice,
lacking the enzyme required for the formation
of estrogen from testosterone, have defective
spermatogenesis, which is associated with in-
creased germ cell apoptosis (163). In agreement
with the results of these rodent studies, our
study group has demonstrated the ability of
estradiol to suppress human male germ cell
death in vitro (166).
6.3.3.2 Death receptors
In various situations, triggering of apoptosis
occurs via cell surface receptors called death
receptors (DRs) (167). Activation of the DRs,
such as Fas (CD95, APO-1) or TNFα receptor 1
review of the literature
26
(TNFR1), by their ligands, such as the Fas ligand
(FasL) or TNFα, respectively, leads to recruit-
ment of specific signaling molecules, which link
the receptors to the apoptotic pathways (Fig. 3)
(15, 128, 168). DR-mediated apoptosis may oc-
cur in either a mitochondria-independent or –
dependent manner (130). Furthermore, signal-
ing molecules recruited by the activated DRs
may also, especially in the case of TNFR1 acti-
vation, mediate functions that are distinct from
or even counteract apoptosis (169). In the tes-
tis, Fas appears to be activated by several
apoptosis-inducing insults (170-172). The
proapoptotic FasL expressed by the Sertoli cells,
and perhaps also by the germ cells (173), has
been suggested to activate the membrane-bound
Fas receptors and thereafter the apoptotic
cascade(s) in the germ cells (25, 171, 172, 174-
179). However, additional regulation of
apoptosis by the Fas system may also exist,
since FasL has also been found in germ cells
and Fas in Sertoli cells (173, 180). Furthermore,
a soluble Fas appears to be a potential germ cell
survival factor in the seminiferous tubules (180).
In contrast to the pro-apoptotic FasL, TNFα
appears to act as a germ cell survival factor.
This anti-apoptotic effect of TNFα on germ cells
probably takes place via a paracrine mechanism,
which may occur by down-regulation of FasL
(181). Other possible effects of TNFα include
modulation of lactate generation, testosterone
production, sphingosine systems, and activa-
tion of the transcription factor AP-1 (169, 182-
187).  NF-κB activation, which in non-testicular
cells is often associated with the survival sig-
nals of the TNF system, does not seem to ex-
plain the anti-apoptotic effect of TNFα  in the
testis, but rather to be associated with pro-
apoptotic events in the germ cells (181, 188).
6.3.3.3 Caspases
Most of the apoptotic pathways (both mito-
chondrial-dependent and –independent) in-
volve the action of specific proteases called
caspases, which cleave their substrates on the
carboxyl site of aspartate residues (14, 15, 168,
189). The caspases act at several phases of
apoptosis. For example, caspase-8 is activated
during the initiation phase, whereas caspase-9
and caspase-3 are active during the downstream
events of the effector or the execution phases
of apoptosis (Fig. 3). Activation of caspases
leads to cleavage of proteins, which, in turn,
results in destruction of essential cell structures,
or inactivation of proteins that protect cells from
apoptosis (e.g. Bcl-2 proteins), or activation of
pro-apoptotic proteins (14, 22, 190). Although
caspases play an important role in controlling
the number of apoptotic events, there also ap-
pear to be cell death pathways that are inde-
pendent of caspase activation (15, 191, 192). In
the testis, caspases appear to be involved in
germ cell apoptosis. Our study group has re-
cently demonstrated that in vitro induced hu-
man germ cell apoptosis is effectively inhibited
by a universal caspase inhibitor, zVAD-fmk (172).
More specifically, at least caspase-3 appears to
be involved in male germ cell apoptosis induced
by reducing the concentration of testicular tes-
tosterone (159). However, the death of sperma-
tozoa may be independent of caspases (23).
6.3.3.4 The  non-mitochondrial
pathway
Non-mitochondrial pathway(s) of apoptosis do
not involve mitochondrial control (even though
some mitochondrial changes may be observed),
but rather include alternative means of recruit-
ment of the executioner proteases and nucleases
(Fig. 3). Both mitochondrial-independent and -
dependent pathways of apoptosis can be trig-
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gered by various inducers, such as numerous
extracellular signals, activation of the DRs, or
changes in the intracellular milieu (126, 168, 190).
Accumulating evidence suggests that, instead
of, or in addition to, the mitochondria, other
cellular organelles such as the endoplasmic
reticulum (ER), the lysosomes, and the Golgi
apparatus, are major points of integration of pro-
apoptotic signaling or damage sensing (130).
6.3.3.5 The mitochondrial pathway
In numerous cell types, the decision (effector)
phase of apoptosis takes place at the level of
the mitochondria (Fig. 3) (17, 69, 124, 126, 127,
130-134, 193). The general mechanisms of mito-
chondrial control of apoptosis are described in
the following paragraphs.
Mitochondrial permeability transition (PT).
Many of the apoptotic pathways converge to
mitochondria and trigger an increase in mito-
chondrial membrane permeability. Both the in-
ner and the outer membrane manifest signs of
permeabilization (69, 132). PT (also called MMP,
mitochondrial membrane permeability transition;
or MPT, mitochondrial permeability transition)
has been suggested to be the mastermind that
orchestrates apoptosis (Fig. 3) (17, 69, 124, 126,
127, 130-134, 194, 195). PT is believed to be
caused by the opening of a large conductance
channel known as the mitochondrial PT pore
complex (PTPC, MTP) (69, 126, 132, 193-197).
This dynamic multiprotein complex is formed of
a voltage-dependent anion channel (VDAC), an
adenine nucleotide translocator (ANT) and
cyclophilin D (CypD) at the contact site between
the inner and outer mitochondrial membranes
(197). Multiple parameters influence the prob-
ability that the PT pores will open. Opening of
the pores is favored by such factors as ROS,
depletion or oxidation of GSH, oxidation of
NAD(P)H and alkalinization (17, 134, 194, 196-
198). Opening of the pores can be inhibited by
several factors, including thiol-reactive agents,
ADP, ATP, and CyP D ligands, such as
cyclosporin A (CsA) and N-methyl-Val4-CsA
(17, 126, 132, 134, 193, 195). In the testis, the
roles of PT and the consequent events (to be
described in the following paragraphs) in the
regulation of male germ cell death were unknown
prior to the present investigations.
Release of apoptogenic factors. During the ex-
ecutioner phase of mitochondria-dependent
apoptosis, the  mitochondria release proteins,
such as cytochrome c, apoptosis inducing fac-
tor (AIF), endonuclease G, and SMAC (second
mitochondrial activator of caspases or Diablo),
into the cytosol (Fig. 3) (15, 69, 126, 127, 130,
132, 133, 195). There, these proteins activate later
apoptotic cascades and perform other functions
essential for apoptosis. For example, cytochrome
c binds to Apaf-1 (apoptotic protease-activat-
ing factor-1) and procaspase-9 (Fig. 3) (15, 127,
199), resulting in the formation of a multiprotein
complex called the apoptosome and activation
of downstream or executioner caspases, such
as caspase-3 (127, 199). The mechanisms by
which mitochondrial proteins are released from
mitochondria have remained enigmatic. One of
the main hypotheses suggests that the escape
of these proteins, which are normally confined
to the intermembrane space of these organelles,
occurs as a consequence of an increase in the
permeability of the outer mitochondrial mem-
brane (PT of OM) (69).
Dissipation of mitochondrial membrane poten-
tial and disruption of electron transport. In many
cell types, activation of the apoptotic pathways
leads to dissipation of the mitochondrial trans-
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membrane potential (∆Ψ
m
) (Fig. 3) (17, 69, 126,
131, 134, 193, 196, 200). The exact explanations
for the collapse of the electrochemical and pro-
ton gradients of the inner membrane (IM) are
unknown (131). One of the possible explana-
tions is permeabilization of the IM (PT of IM)
(69, 195, 196). Compared with that of the OM,
apoptotic IM permeabilization is selective, and
does not result in massive leakage of matrix pro-
teins (69). Furthermore, it seems to be a less
constant feature of apoptosis than OM
permeabilization. In addition to dissipation of
the proton gradient, it is manifested as extru-
sion of small solutes (e.g. calcium and GSH) or
an influx of substances, such as water, which,
in turn, may cause morphological alterations
such as mitochondrial swelling (69, 198). Loss
of the protein gradient together with depletion
of cytochrome c from the mitochondria are
thought to result in disruption of electron trans-
port and oxidative phosphorylation (127, 195),
and a consequent drop in ATP production (Fig.
3) (195, 196). The role of ATP generation in cell
death is detailed below in the paragraph ”pro-
duction of ATP (and other ANs)”.
Alteration of cellular redox homeostasis. Any-
thing that affects the basic functions of mito-
chondria can be assumed to result in modula-
tion of ROS production, redox homeostasis, and
antioxidative capacity, and vice versa (17, 69,
87, 88, 96, 195). The release of proteins from
these organelles, and their consequent absence
from the mitochondria have been suggested to
have deleterious consequences for mitochon-
drial functions. First, the release of AIF, which
is an NADH-oxidizing flavoprotein, as well as
that of oxidant-detoxifying enzymes from the
mitochondria may perturb local redox metabo-
lism (126). Second, release of the proteins in-
volved in protein import may disturb the
reuptake of proteins and the repair of mitochon-
dria (126). Third, permeabilization of the outer
mitochondrial membrane, with consequent loss
of cytochrome c, interrupts the electron flow
between respiratory chain complexes III and IV,
thereby causing an increase in the generation
of ROS (126). Increased generation of ROS, in
turn, together with the uncoupling of the respi-
ratory chain due to the opening of the PTPC,
can be expected to cause oxidation of NAD(P)H,
loss of ATP, and oxidation or depletion of GSH
(126). (ROS as possible regulators of apoptotic
events are discussed in greater detail below in
the paragraph ”reactive oxygen species”).
Bcl-2 family. Proteins of the Bcl-2 family serve
as key regulators of apoptosis in many cell types
(15, 124, 140, 201-205). The Bcl-2 family mem-
bers are usually considered as either anti-
apoptotic (e.g. Bcl-2, Bcl-xL or Bcl-w) or pro-
apoptotic (e.g. Bax, Bak, Bok, Bid, Bad or Bim).
In certain situations, however, some of the pro-
survival factors may act as anti-survival ones
(206). The proteins of the Bcl-2 family are lo-
cated in several cellular organelles, such as the
mitochondria, the endoplasmic reticulum, or the
nuclear envelope, and in the cytoplasm (130,
201-203). Their main (or at least one of their main)
site(s) of action seems to be the OM of the mi-
tochondria, where they are located or into which
they move in response to a death signal. The
Bcl-2 family members appear to interact with each
other, for instance forming channels into the
OM, which in turn, may result in the PT of the
OM (130, 202, 203). However, it has also been
suggested that PT of OM takes place indepen-
dently of the Bcl-2 family, being caused by non-
specific rupture of the OM induced by swelling
of the matrix and expansion of the IM, which, in
turn, would be consequences of PTPC of the
IM (202). Interestingly, there may be coopera-
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tion between the Bcl-2 family members and
PTPC, thus indicating that both models (the
”Bcl-2 family channel model” and the ”PTPC
model”) take place during apoptotic processes
(126, 130, 194, 201, 202). In addition to channel
forming, proteins of the Bcl-2 family have been
suggested to take part, for example, in the con-
trol of oxidative mechanisms, in the regulation
of Apaf-1-family proteins, and in calcium ho-
meostasis (17, 201).
In the testis, the members of the Bcl-2 family are
important regulators of both physiological and
inappropriate apoptosis. Thus, during the first
wave of spermatogenesis, germ cell apoptosis
seems to be regulated by Bcl-2, Bax, Bcl-xL, Bad,
and Bcl-w (23, 39, 140, 204). Apoptotic death of
testicular cells during mature spermatogenesis,
in turn, seems to involve at least the actions of
Bcl-w and Bcl-xL (23, 140, 204, 207). Inappropri-
ate germ cell death, induced, for instance, by
cytotoxic drugs, methoxyacetic acid, blockade
of the action of SCF or by withdrawal of test-
osterone, is associated with the functions of
Bcl-w, Bax and Bak (23, 204). Other members of
the Bcl-2 family, such as Bak, Bok, Bim (also
known as Bod), and DIVA (or Boo) are ex-
pressed in the testis, but their roles in control-
ling cell death and spermatogenesis have re-
mained unclear (23, 140).
Tumor suppressor p53. The mechanisms under-
lying regulation of cell death cascades by the
proapoptotic p53 involve both transcription-
dependent and transcription-independent func-
tions, the latter mainly taking place at the level
of mitochondria (208). The action of p53 in-
cludes, for example, formation of ROS, oxida-
tive degradation of mitochondrial components,
and interaction with heat shock protein 70
(Hsp70) in mitochondria, as well as transcrip-
tional regulation of specific target genes, such
as some members of the Bcl-2 family, Fas, or
certain redox-related genes (14, 130, 140, 208).
In the testis, p53 is associated with the regula-
tion of germ cell apoptosis, at least during the
first round of spermatogenesis, and in certain
stress conditions, such as during exposure to
radiation or in cryptorchidism (23, 140, 209-211).
The role of p53 in controlling germ cell death
during mature spermatogenesis is unclear and
may be species specific. Thus, p53 has been
shown to be expressed in seminiferous tubules
of adult rats, but there are data suggesting that
p53 is not active in the normal adult human tes-
tis, which, in turn, would indicate that there are
p53-independent mechanisms of spontaneous
germ cell apoptosis acting in humans (23, 140,
212).
Sphingolipids. Sphingolipids, such as ceramide,
which is formed from sphingomyelin (SM), and
glycosphingolipids, such as ganglioside GD3,
are also involved in the regulation of apoptosis
(88, 130, 213-215). In addition to their other func-
tions, sphingolipids appear to be involved in
mitochondrial events leading to cell death. Ac-
tivation of the SM-ceramide pathway is associ-
ated with generation of ROS and other mito-
chondrial functions. On the one hand, ROS-in-
duced apoptosis appears to result in ceramide
formation, a view which is supported by the
ability of NAC (an antioxidant) to inhibit degra-
dation of SM to ceramide while suppressing cell
death (88). On the other hand, ceramide seems
to induce overproduction of ROS by acting on
the respiratory chain (complex III), and to take
part in the release of cytochrome c and a de-
crease in mitochondrial transmembrane poten-
tial. Moreover, the functions of some
proapoptotic molecules, which trigger ceramide
production, are associated with complex III (88).
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Thus, in cell death, a positive feedback may ex-
ist between ROS and ceramide production (88).
Ceramide generation also regulates glyco-
sphingolipid and ganglioside metabolism. In
particular, ganglioside GD3 biosynthesis seems
to take part in controlling apoptosis, as GD3
appears to induce mitochondrial damage directly
and to trigger the release of apoptogenic fac-
tors (130, 213-215). In the testis, the roles of
sphingolipids in controlling cell death are not
known, but in female germ cells the SM-ceramide
pathway appears to be fundamental in regulat-
ing apoptosis (216, 217).
6.3.3.6 Production of ATP (and
other ANs)
ATP production appears at the same time to be
the target and the modulator of cell death events.
On the one hand, the apoptotic process changes
the levels of ATP and, on the other hand, ATP
itself seems to control cell death (69, 193, 196,
202, 218-224). In some cell types, apoptosis is
associated with a decline in ATP stores (218,
219). As described above, suppression of ATP
generation has been suggested to result from
collapse of the H+-gradient caused by PT, and
consequent cessation of OXPHOS (126, 196,
201). On the other hand, it has been proposed
that the main factor explaining the fall in ATP is
perturbation of mitochondrial ATP/ADP ex-
change (caused by apoptotic cascades), which
is followed by other mitochondrial defects, such
as PT, and lead to a decreased rate of OXPHOS
(219). Furthermore, there are several other pos-
sible explanations for the fall in ATP, such as
increase in ATP hydrolysis or in ATP consum-
ing reactions. Thus, the mechanism underlying
the drop in ATP levels has remained unclear.
Although evident, the role of ATP production
in the regulation of cell death is also somewhat
contradictory, and appears to depend on the
cell type and the inducer of death. In non-tes-
ticular cells, suppressors of mitochondrial ATP
production, such as inhibitors of OXPHOS, or
anoxia/hypoxia, have been shown to modulate
cell death. However, their mode of action is con-
troversial, since they appear to induce, delay,
or inhibit cell death, or to switch apoptosis to
necrosis (16, 69, 202, 220, 225-237). The conse-
quences of simultaneous blocking of glycoly-
sis have also varied from no effects to switch-
ing the type of cell death from PCD to necrosis
or cytotoxicity (230, 237-240). In some cell types,
ATP is proposed to be necessary for the
apoptotic program, whereas in other cell types,
death pathways independent of ATP produc-
tion have been described (69, 126, 127, 220, 221,
233). Interestingly, it has also been suggested
that it is not ATP per se but rather the func-
tional respiratory chain or certain contributors
of energy production themselves, such as F1F0-
ATPase, that are essential for the control of cell
death (16, 126, 131, 219, 229, 241-244).
In addition to ATP, other ANs (ADP and AMP)
seem to be modulators and targets of cell death
(16, 126, 218, 219, 229, 241-244). ATP and ADP,
which are ligands of ANT, have been shown to
suppress apoptosis via interactions with the PT
pore complex (which includes ANT as one of
its proteins) (126, 197, 243). Interestingly, how-
ever, whether the ANT ligand inhibits or favors
the probability that the PT pore will open de-
pends on the state of the ANT, which operates
as a gated pore (197). The ANT alternates be-
tween two conformations in which the ADP/
ATP- binding site is either on the matrix side of
the inner membrane (m-state) or the cytoplas-
mic side (c-state). Ligands binding to the m-
state (e.g. boncreate) inhibit, and those binding
to the c-state (e.g.atractylosite) activate PT pore
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opening. Thus, because of the conformational
changes in ANT, the roles of its ligands in regu-
lating PT are not necessarily unequivocal. Be-
sides the effects on ANT, ADP has been shown
to affect the regulation of apoptotic events by
promoting CsA binding to CypD (197). How-
ever, the overall effects and mechanisms of ADP
and especially of AMP on the process of cell
death, and vice versa, have remained poorly
characterized
Prior to the present studies, the roles of genera-
tion of ATP (and other ANs), in testicular cell
death were unknown. However, situations such
as ischemia-inducing testicular torsion/
reperfusion and administration of fluoroacetate,
may indicate involvement of ATP in controlling
testicular death, since these both affect germ
cell death and probably change the ATP levels
(37, 38, 245) .
6.3.3.7 Reactive oxygen species
Irrespective of the death-inducing signal, oxi-
dative changes and production of ROS have
often been suggested to play roles in the
apoptotic death of many cell types (17, 69, 87,
88, 89, 96, 116, 195, 200, 246-251). Several obser-
vations support these suggestions (Table 2).
First, increased intracellular ROS generation has
been proposed to represent a conserved
apoptotic event (20, 88). Second, activation of
apoptotic cascades has been shown to occur
as a consequence of increased generation of
ROS or treatment with exogenous oxidants (69,
88, 248). Third, various antioxidants and
antioxidative enzymes are able to delay or block
apoptosis (87, 88, 116, 247, 248). Reciprocally,
some broad-spectrum antiapoptotic proteins
(e.g. Bcl-2) have been described as antioxidants,
indicating that ROS generation may be part of
the cell death effector machinery (88). Further-
more, triggers and suppressors of apoptosis
have been shown to modulate antioxidant de-
fenses. For example, apoptosis triggered by with-
drawal of growth factors has been suggested
to involve down-regulation of antioxidant de-
fenses, resulting in increased sensitivity to the
ROS produced during normal metabolism (87,
252). On the other hand, hormones have been
proposed to modulate the expression of genes
encoding for key antioxidant enzymes and to
regulate the intracellular redox state, while sup-
pressing apoptosis (87, 88). Finally, a number of
observations have demonstrated that depletion
of cellular GSH is an early event in damage-in-
duced apoptosis (69, 88, 248). However, despite
various studies suggesting that ROS and redox
homeostasis are important regulators of
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apoptotic cell death, their exact role and the
causal relations are unclear. Actually, there are
data indicating that ROS may be neither com-
mon nor obligatory mediators of all forms of
apoptosis (17, 249), and it has been questioned
whether the observed accumulation of ROS is a
causal factor or only a side effect of the other
changes accompanying the apoptotic process
(17). In the testis, the role of ROS in the regula-
tion of germ cell apoptosis has remained un-
clear. However, ROS have been shown to affect
the viability of spermatozoa (253, 254), and thus,
ROS could also be hypothesized to take part in
the control of germ cell death.
6.3.3.8 Other regulators of
apoptosis
In addition to the regulators listed above, the
testicular cells express numerous organ-specific
factors, such as testicular cytochrome c (cyt ct)
and heat shock protein 70-2 (Hsp 70-2), which
are possible regulators of apoptosis, but the
roles of which have often remained unsolved
(43, 45, 55, 78, 255). Furthermore, there exist nu-
merous other modulators of cell death, the ef-
fects of which appear to depend on the cell type
and the inducer of apoptosis.
6.3.4 Clinical implications
Germ cell death appears to play a role in several
problems connected with the pathogenesis of
male reproductive health. Dysregulation of germ
cell apoptosis, leading either to the absence of
appropriate death or to its inappropriate occur-
rence, is associated with such conditions as
cryptorchidism, infertility, germ cell tumors, and
testicular torsions (9, 24, 28-42). During recent
decades, epidemiological tendencies have
shown an increased incidence of cryptorchid-
ism in children and of testicular cancers in ado-
lescents or adult men, as well as lowered (or at
least not improved) sperm counts in normal
adult men (42, 256-262). Environmental or
lifestyle factors have been suggested to be in-
volved in these reproductive disorders, but the
precise causes of these trends, which appear to
show regional differences, are not known (42,
256, 260, 262, 263).
Cryptorchidism is the most common congenital
abnormality in newborn boys (28, 29). Interest-
ingly, cryptorchidism has been shown to be a
significant risk factor for testicular cancer and
an important cause of infertility (29, 31, 258, 262,
263). The pathogenesis of the testicular cancer
and reduced fertility seen in cryptorchidism has
not been fully clarified. Germ cell counts in cryp-
torchid testes have been reported to fall, prob-
ably by an apoptotic mechanism, below the
normal range between one and two years of age
(7, 28). This reduction in the number of germ
cells has been suggested to be involved in the
impaired fertility, because the cryptorchid pa-
tients with the lowest total germ cell counts have
the poorest spermiograms in adulthood (7, 28,
29). For decades, hCG (+/- surgery) has been
used (and is still used) in treating cryptorchid
patients. However, this treatment has been as-
sociated with an increase in germ cell apoptosis,
which in turn is associated with smaller testis
volume, lower sperm densities, and higher FSH
levels in adulthood (28, 29). Therefore, a critical
re-evaluation of this treatment and consider-
ation of new treatments have been proposed
(28).
In addition to the impaired infertility associated
with cryptorchidism, idiopathic reduction in male
fertility appears to account for the increase in
the number of men seeking advice about infer-
tility (28, 29, 257, 258, 264). Despite some indica-
tions of the involvement of environmental fac-
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tors or the dysregulation of ROS generation in
the pathogenesis of idiopathic infertility, the
exact mechanisms underlying this problem are
not known (7, 254, 256, 258, 265-268). Therefore,
even though NAC, for example, has been sug-
gested to be a possible medication on account
of its antioxidative properties (254), there are no
targeted methods for treating these patients.
Hitherto, the treatments for male infertility have
been based on ex vivo procedures, such as in
vitro fertilization (IVF) techniques, which in-
clude recently introduced fertilizations of oo-
cytes by injections of spermatids (269, 270). The
fertilization rates of these techniques, in which
spermatids are used, have been relatively low,
which may reflect increased germ cell apoptosis
induced by the manipulating conditions (269,
270). Thus, prevention of inappropriate germ
cell death could be one of the focuses in at-
tempts to improve the success rates of these
procedures. Moreover, one of the main tasks
has been suggested to be investigation of the
mechanisms underlying the fertility problem,
such as dysregulation of germ cell proliferation
and death (23, 24, 266). An understanding of
the pathophysiology, in turn, would enable de-
velopment of treatments for males with this
problem, who could then be treated rather than
their healthy female partners (who receive
strong hormonal medications during the IVF
procedures) (23, 24, 266).
In patients suffering from testicular as well as
from non-testicular cancers, dysregulation of
germ cell apoptosis is associated with impaired
testicular functions (42, 150, 271, 272). The ma-
lignant cells of testicular cancer often represent
transformed germ cells (42). Lack of appropriate
apoptosis that would remove these harmful cells
is characteristic of the cancer cells, as well as of
many other types of cancer cells (19, 21, 273). In
contrast to lack of apoptosis, inappropriate in-
duction of germ cells is associated with the treat-
ment of cancers. For example, the radiation and
chemotherapeutic compounds used as cancer
therapies appear to induce male germ cell death,
and lead to fertility problems (146, 147, 149, 150,
271, 272). As numbers of cancer patients are of
fertile age or are children, and as their prog-
noses in terms of the cancers has improved, so
that up to 80% survive, there is a growing need
to understand the mechanisms of, and to pre-
vent or treat, the adverse effects of the cancer
treatments (271, 272).
Since the male gonadal dysfunctions described
above are associated with germ cell death, an
understanding of the regulation of the death
pathways of testicular cells is required when
developing targeted methods for diagnosing,
treating, and preventing these situations. On
account of the possible (and probable) species-
specificity, data on the control of human tes-
ticular cell death is preferential. However, prior
to the present studies, knowledge of male germ
cell apoptosis was based mainly on experimen-
tal animals.
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7. Aims of the Study
Understanding of testicular physiology and pathology requires knowledge of the regulation of
human male germ cell death. Since, prior to the present study, knowledge of germ cell apoptosis
was based mainly on investigations in rodents, a model for evaluating human testicular cell death
was required. Thus, the aims of the present study were as follows:
1) To create an in vitro tissue culture model in which regulation of human testicular cells could be
studied in conditions maintaining the physiological interactions of the cells in the seminiferous
epithelium.
2) To evaluate the role of the mechanisms related to mitochondrial functions in the regulation of
male germ cell death, with emphasis on oxidative events, ATP production, and mitochondrial
permeability transition.
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8. Materials and Methods
8.1  THE IN VITRO TIS-
SUE CULTURE
8.1.1 Patients
Testis tissue was obtained from 87 adult men
aged 28-88 years undergoing orchidectomy. The
operations were performed at the Department
of Urology, Helsinki University Central Hospi-
tal (Helsinki, Finland) and at the Helsinki City
Health Department, Surgical Unit, Helsinki, Fin-
land. The majority, i.e. 79, of the patients under-
went orchidectomy as treatment for prostate
cancer. They had not received hormonal, che-
motherapeutic, or radiotherapeutic treatments
before the operation, and none of them had suf-
fered from endocrinological disease or cryp-
torchidism. Certain findings (described below
in the paragraph “results and discussion”) ob-
tained using tissue from prostate cancer patients
who were elderly men, were confirmed by using
testes tissues derived from 8 younger men suf-
fering from testicular cancer, using samples taken
from an unaffected area. The Ethics Commit-
tees of the Departments of Children and Ado-
lescents and of Urology, University of Helsinki,
approved the study protocol.
8.1.2 Tissue preparation
Immediately after the testis tissues from the
operations were obtained, segments of seminif-
erous tubules (1 to 5 mm in length) or small pieces
of testicular tissue (sized ca 1 mm x 1 mm x 2 mm
to 1 cm x 1 cm x 1 cm) were microdissected under
a transillumination stereomicroscope in a Petri
dishes containing phosphate-buffered saline
(PBS) supplemented with human serum albu-
min (Sigma Chemical Co., St. Louis, MO, USA)
(+/- treatments), see papers I-III and V, or cul-
ture medium (+/- treatments), see paper VI.
For the squash preparations, segments of semi-
niferous tubules (1 to 3 mm in length) were dis-
sected and transferred in 10-20 µl of medium
onto microscope slides and gently squashed
under coverslips. This method enables the cells
from the seminiferous epithelium to move out
from the tubules and produce a monolayer on
the microscope slide (Paper IV, Fig. 3A; Paper V,
Fig. 2A, small insert). For Southern blot analy-
sis of DNA fragmentation, for in situ detection
of apoptotic DNA, for morphological analysis
by electron microscopy, and for high perfor-
mance liquid chromatography (HPLC), the
samples were processed as described below.
8.1.3 Induction of apoptosis and
necrosis
For induction of apoptosis, the samples were
transferred to culture plates and incubated in
tissue culture medium [nutrient mixture Ham´s
F10, containing 6.1 mM (1100 mg/l) of D-glu-
cose and 1 mM (110 mg/l) of sodium pyruvate,
Invitrogen, GibcoTM Invitrogen Corporation,
Europe, Paisley, UK], supplemented with 0.1%
human serum albumin (Sigma), and 10 µg/ml
gentamicin (Invitrogen), for increasing lengths
of time (4, 8, 24, 48, and 72 hours). The incuba-
tions were performed at 34oC in humidified room
air, with CO2 adjusted to 5%. For  induction of
necrosis, segments of seminiferous tubules
were exposed to a high (toxic; 10 mM) concen-
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tration of an oxidant, hydrogen peroxide (H2O2;
Merck, Darmstadt, Germany).
8.1.4 Treatment with testosterone
To evaluate the ability of testosterone to sup-
press in vitro -induced human male germ cell
apoptosis, the samples were cultured for differ-
ent lengths of time (4, 24, and 48 hours) in the
absence or presence of testosterone (Sigma).
Testosterone stocks were prepared in absolute
ethanol. The final concentrations of testoster-
one were 10-6 M, 10-7 M, and 10-8 M, and the
control samples contained the same amount of
ethanol as the testosterone samples.
8.1.5 Exposure to N-Acetyl-L-cysteine
(NAC)
To investigate the role of a thiol antioxidant,
N-Acetyl-L-cysteine (NAC), in the regulation of
human testicular apoptosis, segments of semi-
niferous tubules were incubated for increasing
lengths of time (4, 24, and 48 hours) in the ab-
sence or presence of N-Acetyl-L-cysteine
(Sigma). For the stocks, NAC was diluted in 1
M NaOH, after which the pH was adjusted to
7.5, and NAC aliquots were stored at -20 oC. In
the culture, the final concentrations of NAC
were 125 mM, 100 mM, 50 mM, and 25 mM.
8.1.6 Cultures in different partial
oxygen pressures
To study the effects of lowering of the oxygen
tension on testicular cell death, segments of
seminiferous tubules were incubated in differ-
ent partial oxygen pressures. The control cul-
tures were performed at 34oC in humidified room
air (21% of O2), with CO2 adjusted to 5%. The
samples were exposed to 10%, 5%, 2%, and 0.5%
of O2 in humidified tight glass chambers under
continuous gas flow (minimum 1L/h) from gas
bottles (Aga, Espoo, Finland) containing the
different concentrations of O2, and 5% of CO2,
the remainder being nitrogen. The gas analyses
were performed by Aga (Espoo, Finland) ac-
cording to their quality controlled standard
methods.
8.1.7 Treatment with inhibitors of
mitochondrial permeability transition
(PT)
Whether mitochondrial PT plays a role in con-
trolling male germ cell death was investigated
by using inhibitors of PT. Testicular tissue
samples were incubated in the absence or pres-
ence of cyclosporin A (CsA, Sigma), which
binds to mitochondrial cyclophilin D. To exclude
the immunosuppressive effects of CsA as pos-
sible modulators of cell death, the ability of its
non-immunosuppressive derivative N-methyl-
Val4-CsA (which inhibits PT) to suppress germ
cell death was also investigated. The final con-
centrations of CsA were 10 µM, 5 µM, and
0.5 µM, and of N-methyl-val4-CsA (kindly pro-
vided by Dr. Ove Eriksson) 10 µM.
8.1.8 Induction of chemical anoxia by
blockade of oxidative phosphoryla-
tion (OXPHOS) and inhibition of
glycolysis
The role of chemical anoxia and blockade of
mitochondrial OXPHOS in human testicular cell
death was studied by adding potassium cya-
nide (KCN, Sigma), which inhibits cytochrome
c oxidase (complex IV), to the culture medium at
final concentrations of 5 mM and 10 mM. Cyto-
solic ATP production was inhibited by block-
ing glycolysis with 2-deoxyglucose (2-DG,
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Sigma) concentrations of 5 mM or 10 mM. High
concentrations of KCN and 2-DG were used to
ensure total inhibition of OXPHOS and glyco-
lysis, respectively. Furthermore, NADH-
ubiquinone oxidoreductase (complex I) was in-
hibited with rotenone concentrations of 10 µM
and 100 µM. The stock solutions of the reagents
were prepared in Krebs-Henseleit buffer (115
mM NaCl, 3.6 mM KCl, 1.3 mM KH2PO4, 25 mM
NaHCO3, 1 mM CaCl2, 1 mM MgCl2, pH 7.2) or
ethanol as appropriate, and the pH was neutral-
ized prior to culture.
8.1.9 Exposure to lactate or extra
pyruvate
To evaluate the role of lactate on human tes-
ticular apoptosis, lactic acid (lactic acid; equal
amounts of the D- and L-isomers; Sigma) was
added to the culture medium at final concentra-
tions of 1 mM, 5 mM, and 10 mM, which corre-
spond to its physiological concentrations in the
testicular tissue (274). In addition, lactate con-
centrations of 20 mM and 25 mM were tested.
To assess whether concentrations of pyruvate
exceeding the basal concentration of the me-
dium would affect testicular cell death, extra
sodium pyruvate (Sigma) was added to the cul-
ture at final concentrations of 5 mM, 10 mM,
and 50 mM. In all experiments, the pH was neu-
tralized prior to culture.
8.1.10 Activation of the Fas receptors
Agonistic anti-Fas antibody has been shown
to activate the apoptosis of testicular germ cells
(176). To investigate whether activation of the
Fas receptors would modulate the antiapoptotic
effects of lactate, NAC or KCN, an agonistic
anti-Fas antibody (Roche Molecular
Biochemicals, Mannheim, Germany) was added
to the cultures at final concentrations of 2 µg/
ml and 5 µg/ml. Because of the possibility that
the antibody would not be functional in the
present culture conditions (even though it main-
tains its activity in non-testicular systems), re-
combinant human Fas ligand (Fas-L)
(CALBIOCHEM-Oncogene Research Products,
San Diego, CA) was also tested, instead of acti-
vating anti-Fas antibody, in the pilot experi-
ments. The final concentrations of Fas-L were
0.5 and 1.0 µg/ml.
8.2 DETECTION OF CELL
DEATH
8.2.1 Southern blot analysis of DNA
fragmentation
Testis tissue samples were snap-frozen in liq-
uid nitrogen and stored at -70oC until isolation
of DNA. For the extraction of genomic DNA in
studies I-III, the tissues were homogenized with
an Ultra-Turrax T8 homogenizer in homogeni-
zation buffer (0.1 M NaCl; 0.01 M EDTA, pH
8.0; 0.3 M Tris-HCl, pH 8.0; 0.2 M sucrose). The
homogenates were transferred to
microcentrifuge tubes containing 10% SDS,
mixed and incubated at 65oC for 30 min. After
incubation, 8 M of potassium acetate was added
and the samples were incubated on ice for 60
min. The samples were then centrifuged at 6
000g for 20 min at 4oC, and the supernatants
were collected and extracted twice with
phenol:chloroform:isoamyl alcohol (25:24:1,
v:v:v), followed by re-extraction with
chloroform:isoamyl alcohol (24:1, v:v). The up-
per aqueous phases were collected and precipi-
tated by addition of absolute ethanol and incu-
bation at -70oC. The nucleic acids were collected
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by centrifugation at 14 000g for 30 min at 4oC.
Pellets were resuspended in TE buffer (10 mM
Tris-HCl, 1 mM EDTA, pH 8.0) and digested by
addition of DNAase-free RNAase (Roche) fol-
lowed by incubation at 37oC for 60 min. Samples
were then extracted with phenol: cholroform:
isoamyl alcohol, followed by extraction with
chloroform:isoamyl alcohol. The supernatants
were collected and DNA was precipitated by
addition of 3 M sodium acetate and ice-cold
absolute ethanol, followed by incubation at -
70oC. The DNA was collected by centrifugation
at 14 000g for 30 min at 4oC, washed with ice-
cold 80% ethanol, and dried under a vacuum.
Pellets were resuspended in sterile water for
quantitation and labeling.
In studies IV-V, DNA was extracted by using
the Apoptotic DNA Ladder Kit (Roche) accord-
ing to the manufacturer’s instructions, with some
modifications, as recently described (166).
Briefly, the samples were homogenized with the
Ultra-Turrax T8 homogenizer and incubated in
binding/lysis buffer (6 M guanidine-HCl, 10 mM
urea, 10 mM Tris-HCl, and 20% TritonX-100,
pH 4.4) for 10 min at room temperature. The
samples were then mixed with isopropanol (fi-
nal proportion of isopropanol, 25%), loaded into
polypropylene tubes, and centrifuged for 1 min
at 8000 rpm. The tubes were washed twice with
washing buffer (20 mM NaCl and 2 mM Tris-
HCl, pH 7.5), and the bound DNA was eluted
from the tubes with 10 mM Tris, pH 8.5. Finally,
the samples were incubated with ribonuclease
(2.5 µg/ml; deoxyribonuclease-free ribonuclease,
Roche) for 20 min at room temperature.
After its isolation, the DNA was quantified by
spectrophotometry (absorbance at 260 nm).
DNA samples (1 µg) were 3'-end-labeled with
digoxigenin-dideoxy-UTP (Roche) by use of the
terminal-transferase (Roche) reaction, subjected
to electrophoresis on 2% agarose gels, and blot-
ted onto a nylon membrane overnight. Next day,
the DNA was crosslinked to the membrane by
UV irradiation. The membrane was washed for 5
min with sodium maleate buffer (0.1 M maleic
acid, 0.15 M NaCl, pH adjusted to 7.5 with NaOH),
and blocked for 30 min with 1% blocking re-
agent (Roche) in sodium maleate buffer. The 3´-
end-labeled DNA on the membranes was located
with alkaline phosphatase-conjugated anti-
digoxigenin antibody by incubation for 30 min
in antibody solution (Anti-Digoxigenin-AP;
Roche; 1:10 000 in blocking solution). After
washing twice for 15 min with washing buffer
(0.3% Tween-20 in maleic acid buffer), the mem-
brane was equilibrated for 5 min in detection
buffer (0.1 M Tris-HCl, 0.1 M NaCl, 50 mM
MgCl2, pH 9.5), and the bound antibody was
detected by the chemiluminescence reaction
(CSPD; Roche) at room temperature for 5 min,
and enhanced at 37oC for 15 min. X-ray films
were exposed to the chemiluminescence and
were then scanned with a tabletop scanner
(Microtec ScanMaker, Microtec International,
Inc., Taiwan) and the digitized information (op-
tical density) was analyzed with the MCID Im-
age Analyzing System (Imaging Research,
Canada) in paper I, or with NIH-Image (1.61)
analysis software (National Institutes of Health,
Bethesda, MD, USA) in papers II-V. The
amounts of low-molecular-weight DNA frag-
ments [<1.3 kilobases (kb)] in the 0-hour samples
were set at 1.0 (100%), to which the amounts of
low-molecular-weight DNA fragments in the
other samples were compared. Thus, the results
are expressed in relation to the starting point (0
h, i.e. the samples before culture).
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8.2.2 In situ end-labeling (ISEL) of
DNA
Segments of seminiferous tubules were
squashed and fixed as previously described (51,
275). Briefly, the microscope slides were frozen
in liquid nitrogen, the coverslips were removed
and the frozen slides were dipped into ice-cold
ethanol, and then fixed for 10 min in formalin
and washed in PBS. The slides were then kept
in ethanol:acetic acid (2:1) for 5 min at -20 oC,
then washed in PBS, dehydrated, and stored at
-20 oC until they were stained. Alternatively, the
tissue samples were fixed in glutaraldehyde or
Bouin’s solution, embedded in paraffin, sec-
tioned at 4 µm, and mounted on slides coated
with Vectabond (Vector Laboratories,
Burlingame, CA). The paraffin sections were
incubated at 60°C for 30 min and deparaffinized
in xylene. Both paraffin sections and squash
preparations were rehydrated and permeabilized
in a microwave oven for 5-10 min in 10 mM citric
acid (pH 6.0). The samples were then
preincubated with terminal transferase reaction
buffer (1 M potassium cacodylate, 125 mM Tris-
HCl, 1.25 mg/ml BSA, pH 6.6). The DNA in the
samples was 3’-end-labeled with Dig-dd-UTP
(Roche) by the terminal transferase (TdT, Roche)
reaction for 1 h at 37ºC. Then after exposure to
blocking solution (2% Blocking reagent, Roche,
in 150 mM NaCl, 100 mM Tris-HCl, pH 7.5), the
Dig-dd-UTP-labeled 3’-ends of DNA were de-
tected with antidigoxigenin antibodies conju-
gated either with alkaline phosphatase (Anti-
Digoxigenin-AP, Roche; studies I-II) or with
horseradish peroxidase (Anti-Digoxigenin-POD,
Roche; studies III-V). The antibodies were lo-
cated with substrates for alkaline phosphatase
(NBT, X-phosphate; Roche) or peroxidase
(diaminobenzidine; Sigma). The samples were
weakly counterstained with hematoxylin and
dehydrated. For the negative controls, the TdT
enzyme was replaced with an equal volume of
distilled water.
8.2.3 Electron microscopy (EM)
Segments of seminiferous tubules were fixed in
2.5% glutaraldehyde in 0.1 M phosphate buffer,
pH 7.2, postfixed with 1% osmium tetroxide in
0.1 M phosphate buffer, dehydrated, and em-
bedded in epoxy resin. They were then sec-
tioned at 50 nm with a Reichert E ultramicro-
tome (Reichert Jung, Vienna, Austria) and
stained with uranyl acetate and lead citrate.
Observations were made with a JEOL JEM 1200
EX transmission electron microscope (JEOL,
Tokyo, Japan).
8.3 HIGH PERFORMANCE
LIQUID CHROMATOGRA-
PHY (HPLC)
Samples of testicular tissue were snap-frozen in
liquid nitrogen. To extract the adenine nucle-
otides (ANs; ATP, ADP and AMP), the tissues
were homogenized in 0.42 N ice-cold perchloric
acid. The homogenates were then neutralized
with 4.42 N KOH and centrifuged. During these
procedures the samples were kept on ice. The
ATP, ADP, and AMP concentrations in the su-
pernatants were determined by high perfor-
mance liquid chromatography (HPLC) using a
Shimadzu LC 10AD vp liquid chromatograph
with a reversed phase column (Ultra Techsphere
5 ODS, Labtronic Oy, Vantaa, Finland) and an
UV detector set at 254 nm. The published method
(276) was modified as follows: buffer A (0.1 M
KH2PO4, 8.0 mM tetrabutylammonium hydrogen
sulphate, pH 6.0) was run at 1.5 ml/min for 2.5
min, followed by a linear increase during 10 min
to 100% buffer B (buffer A with 30% methanol),
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which was continued for 2.5 min and followed
by a linear increase during 1 min to 100% buffer
A, which was run for 4 min. The compounds
were identified and quantified by comparison
with the retention times and peak areas of known
standards, calibrated by spectrophotometry.
The AN concentrations were expressed in rela-
tion to testis tissue wet weight (µmol/g of tes-
tis). The adenylate energy charges (ECs) were
calculated from the ATP, ADP, and AMP con-
centrations, according to the following equa-
tion ([ATP] + 1/2[ADP]) /  ([ATP] + [ADP] +
[AMP]). The validity of the HPLC analysis was
tested i) by determining the AN levels of bo-
vine bronchial epithelial cells and of rat cortical
neurons, in which the AN levels correlated with
the results obtained from other study groups;
and also ii) by quantifying the AN levels by
thin layer chromatography by using cells
prelabeled with 14C-adenine.
8.4 REPLICATION OF EX-
PERIMENTS AND STATIS-
TICAL ANALYSIS
All the experiments were repeated on two to
fifteen independent occasions. The quantita-
tive data represent digitized information (opti-
cal density) obtained from the X-ray films of the
Southern blot analysis of DNA fragmentation.
For statistical comparisons, data obtained from
the replicate experiments (mean ± SEM) were
analyzed either by the Wilcoxon Test or by one-
way analysis of variance followed by the Stu-
dent-Newman-Keuls test or the post hoc test
with Bonferroni correction. A p-value < 0.05 was
considered significant.
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9. Results and Discussion
9.1. IN VITRO CULTURE
MODEL
Understanding of testicular physiology and
pathology requires knowledge of the regulation
of testicular cell death. Prior to the present in-
vestigation, knowledge of germ cell death was
based mainly on animal studies. Due to the po-
tential species-specific differences in cellular
responses, a model for evaluating human tes-
ticular cell death was considered necessary.
Because of the importance of cell-cell interac-
tions in the regulation of the functions of semi-
niferous tubules (1-3, 8, 9, 23, 47), a model was
created in which contacts between the cells of
the seminiferous epithelium were maintained.
Thus, instead of incubating isolated cells, seg-
ments of human seminiferous tubules or pieces
of testicular tissue were cultured.
The testis tissues were obtained from patients
of two types. The majority of the samples came
from adult men undergoing orchidectomy as a
primary treatment for prostate cancer. The op-
erations were performed to end the production
of testicular hormones which stimulate prolif-
eration of the cancer cells. Thus, the cancer cells
originated from the prostate and the testicular
tissues of the patients were normal. However,
since some of the patients were quite old, there
was a possibility of age-related hormonal, vas-
cular and oxidative changes within their testes,
which may have affected the regulation of cell
death (25, 89, 277). Although these patients had
not received any endocrinological medication,
their other concomitant medications could have
modulated the results. Therefore, certain find-
ings (induction of apoptosis and its inhibition
by testosterone, NAC, low oxygen tensions and
CsA) obtained with tissue from these elderly
men were confirmed by experiments with
samples from younger men suffering from tes-
ticular cancer, using samples taken from an un-
affected area. The results obtained from these
two groups of patients were alike, which sug-
gests that age is not a significant factor in the
control of testicular cell apoptosis in the present
culture model. Naturally, it would have been
optimal to obtain samples from healthy young
men, but the required size of the tissue sections
was so large that it would have been unethical
to ask for such samples.
9.1.1 Induction of apoptosis in semin-
iferous tubules
Testicular cell apoptosis was induced by cul-
turing segments of human seminiferous tubules
under serum- and hormone-free conditions at
34oC in humidified room air (21% O2), with CO2
adjusted to 5%. Apoptosis was primarily re-
vealed by molecular weight DNA fragmentation
(185 bp multiples) with the use of 3’end-labeled
DNA (Paper I, Fig 1). The DNA of the testis
tissue samples, frozen immediately after the
operation (0-hour time-point), showed no
apoptotic ladder pattern (Paper I, Fig 1). A rapid
increase in germ-cell apoptosis was induced by
the culture conditions, as indicated by
apoptotic DNA laddering in the samples cul-
tured for four hours (Paper I, Fig 1). Southern-
blot analysis revealed a time-dependent (0, 4, 8,
24, and 48 h) increase in the intensity of
apoptotic fragmentation (Fig.4; Table 3; Paper
I, Fig. 1).
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Incubation of seminiferous tubules under the
conditions described above had a rapid and sig-
nificant effect on the human germ cells. In vitro
and in vivo studies in rodents have indicated
changes in apoptotic cell death after exposure
for at least 24 hours to various inducers of death
such as hormonal manipulation, radiation, el-
evated temperature, or ischemia/reperfusion (37,
40, 145, 149, 152, 155, 158, our unpublished re-
sults). In the present study, human testicular
cells underwent apoptosis after a mere 4-hour
incubation in vitro, thus indicating species-
specificity in germ cell sensitivity to death-in-
ducing signals.
Although the main trigger of cell death in the
present culture model was probably withdrawal
of survival factors (i.e. serum and hormones)
other factors may also have played a role in the
induction of apoptotic cascades. The testicular
tissue samples were manipulated and incubated
in conditions in which the partial oxygen pres-
sure was 21%, which is considerably higher than
the normal oxygen pressure in tissues in vivo.
Thus, the testis tissue samples were exposured
to relative hyperoxia and consequent oxidative
stress, which are known to affect cellular me-
tabolism and cell death cascades (17, 69, 87, 88,
96, 195, 200, 246, 248). Therefore, in the present
model, relative hyperoxia may have played a role
in the induction of cell death. Since the testis
tissues were microdissected prior to the culture,
mechanical stress and its consequences may
also have modulated the signal cascades of tes-
ticular cells. However, the effect(s) of direct
mechanical stress as inducers of cell death in
the present model are likely to have been negli-
gible or minimal, because (i), the dissection tech-
niques were optimized to be as gentle as pos-
sible, (ii) the apoptotic DNA ladders of large
samples were more intense than those of small
samples, indicating that small sample size sup-
presses the induction of germ cell apoptosis
(data not shown), and (iii) even though the seg-
ments of the tubules were short, there were al-
ways at least hundreds, if not thousands, of
untouched cells among which were the cells that
later died by apoptosis (i.e. the majority of the
dying cells had not been exposed to direct me-
chanical stress).
9.1.2 Apoptosis of different cell types
In the present study, the different types of hu-
man testicular cells undergoing apoptosis were
characterized by using ISEL and/or electron
microscopy. Germ cells in the later phases of
differentiation were the most sensitive to the
present death-inducing culture conditions, since
the apoptotic cells were identified mainly as
spermatocytes and early spermatids (Table 3;
Paper I, Figs. 4-5; Paper II, Figs. 3-4; Paper III,
Fig. 3; Paper V, Figs. 2-3). In addition, it was
possible to identify different stages of apoptosis
in late spermatids, which, because of their spe-
cific morphology, were somewhat atypical (Pa-
per, II Fig. 4). A few spermatogonia were also
observed to undergo apoptosis (Table 3; Paper
V, Figs. 2 and 3). However, the number of
apoptotic spermatogonia was low and many of
the spermatogonia examined did not show any
signs of apoptosis.
That the germ cells were most receptive to ex-
ternal death signals in the later phases of differ-
entiation, is in agreement with the results of
several animal studies. The reason(s) underly-
ing this sensitivity is(are) unclear. However, the
presence of only occasional dying spermatogo-
nia may reflect the suggested importance of a
stable pool of basal spermatogonia for continu-
ous spermatogenesis (1, 2, 4, 5, 55, 278) and the
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consequently stronger resistance of sper-
matogonia to apoptosis-inducing stimuli. Inter-
estingly, in a given segment of a cultured semi-
niferous tubule, different phases of apoptosis
were observed in a certain cell type, for example,
in a segment incubated for 4h, different phases
of apoptosis were seen in pachytene spermato-
cytes (e.g. Paper I, Fig. 4; Paper II, Fig. 3). Thus,
it appears that even among cells at specific
phases of differentiation, there is variation in
the resistance to death-inducing stimuli.
The apoptotic death of somatic cells, namely
Leydig cells and Sertoli cells, could also be in-
duced in the present study. It appears that at
least some the Leydig cells are sensitive to the
apoptosis-inducing conditions of the culture
model, since dying Leydig cells were observed
in the control samples cultured in the absence
of any treatment (Table 3; Paper I, Fig. 5F). The
Sertoli cells, in turn, seem to be more resistant
to death stimuli than the other testicular cells
and, in order to cause apoptotic death of Sertoli
cells, the testis tissue had to be exposed to a
poisonous concentration of KCN (Table 3; Pa-
per IV, Fig 4). Even after this exposure, most of
the Sertoli cells maintained their normal appear-
ance. Consistently with our results, only spo-
radic studies have reported dying Sertoli cells
(279, 280). The reason for resistance of Sertoli
cells to death is not clear, and even though there
is some indication of the involvement of Bcl-2
family members (140, 281), the cellular mecha-
nisms are largely unknown. However, their abil-
ity to survive seems reasonable, because in the
adult testis they are non-proliferative and ter-
minally differentiated cells, and because they
are responsible for various functions that are
essential for the survival and activities of other
cell types within the testis (1-3, 8, 9, 23, 47).
Thus, in order to maintain spermatogenesis af-
ter testicular insults, specific systems for pro-
tecting the Sertoli cells are likely to be required.
9.1.3 Different types of cell death
In order to characterize cell death modes other
than apoptosis in testicular cells and to vali-
date the methods for detecting cell death, seg-
ments of seminiferous tubules were exposed to
compounds known to cause necrosis or toxic
alterations in non-testicular cells (236, 282-284).
Thus, high concentrations of cyanide (KCN)
and/or hydrogen peroxide (H2O2) were added
to the cultures. Interestingly, even in the basic
cultures (i.e. in which no treatments were
added), some of the dying germ cells in the late
phases of death showed signs of necrosis (Pa-
per II, Fig.3D). Thus, the term necrapoptosis
may apply to death of some human germ cells
(Table 3). High concentrations of KCN or H2O2,
in turn, had diverse effects on cell death (Table
3). A toxic concentration of H2O2 induced ne-
crotic alterations in practically every germ cell,
whereas KCN caused different types of mor-
phological changes in testicular cells. Firstly,
EM revealed that some spermatids and sperma-
tocytes and occasional Sertoli cells underwent
apoptosis after exposure to KCN (Paper IV, Figs.
4 and 5). Secondly, changes in some other sper-
matocytes and spermatids were considered to
be typically necrotic. Finally, in some spermato-
cytes and spermatids, abnormal necrotic or toxic
alterations were observed (Paper IV, Figs. 4 and
5). Of the different types of necrotic cell death,
ischemic cell change (ICC), includes morpho-
logical changes that resemble those observed
in some spermatocytes treated with KCN (Pa-
per IV, Fig. 4D) (13). Such changes include dark-
ening and shrinkage of the nucleus and cyto-
plasm, a honeycomb appearance of the nucleo-
lus, and large cytoplasmic vacuoles. However,
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a distinct form of cell death, autophagocytotic
cell death, also resembles the changes observed
in KCN-treated spermatocytes. Thus, the alter-
ations in the germ cells induced by exposure to
KCN appear to overlap with the different cat-
egories of cell death. Somewhat surprisingly,
structural alterations were found only in spo-
radic cells. The mechanism(s) by which KCN
induced the present morphological findings
is(are) not known, but it appears that some indi-
vidual testicular cells are more sensitive than
others to the toxic effects of KCN, and presum-
ably also to other toxicants.
9.1.4 Methods for detecting cell
death
EM is definitely the most reliable method for
studying the type of cell death in individual cells.
However, on account of the limited possibilities
of viewing large areas with the electron micro-
scope, other methods are required for analyses
of the overall well-being of the tissue. In the
present studies, induction of apoptosis under
the present culture conditions, its inhibition by
various compounds such as KCN, and the in-
duction of necrosis by H2O2 were reflected in
Southern blot analysis as clear apoptotic DNA
laddering, its absence, and ”necrotic smearing”,
respectively (Paper IV, Fig 6). Thus, Southern
blot analysis appears to be a valid method for
studying apoptosis and its regulation, as well
as for reliably distinguishing between apoptotic
and necrotic cell death in human testicular tis-
sue. In contrast, in a non-testicular system, ne-
crosis was suggested to result in DNA laddering
which is indistinguishable from that seen in
apoptosis (238). Even though Southern blot
analysis appears to be a specific method for
studying testicular cell death, it is not very sen-
sitive, and a relatively large number of dying
cells is a prerequisite for causing apoptotic
laddering or necrotic ”smearing” in the DNA
lanes. ISEL, in turn, is more sensitive and en-
ables detection of weaker regulatory effects of
the treatments on cell death. Furthermore, it has
the advantage of simultaneous identification of
the dying cell types (e.g. Paper III, Fig. 3). How-
ever, ISEL fails to determine the type of cell death
(at least with the present fixation and staining
protocols), since necrosis also induces DNA
breaks and staining in ISEL, and thus both
apoptotic (e.g. Paper III, Fig.3) and necrotic (Pa-
per IV, Fig. 6) germ cells are stained. Therefore,
it appeared that the simultaneous use of EM,
Southern blot analysis, and ISEL, offered reli-
able detection of human testicular cell death and
its regulation.
In the following paragraphs the results
represent quantitative data obtained
from Southern blot analysis, unless oth-
erwise stated.
9.2 PHYSIOLOGICAL
CONCENTRATIONS OF
TESTOSTERONE SUP-
PRESS MALE GERM CELL
APOPTOSIS
An in vitro culture model naturally has limita-
tions with regard to the approximation of germ
cell physiology and pathology in vivo. How-
ever, studying the regulators of cell death often
requires the use of compounds or doses that
would be unethical to administer to humans prior
to in vitro investigations. Thus, the aim of the
present study was to create a model that would
give the best available way to study testicular
apoptotic mechanisms in conditions as physi-
ological as possible. In order to determine
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whether the present model provides a suffi-
ciently physiological system, the ability of tes-
tosterone to suppresses germ cell apoptosis
was evaluated. Testosterone was chosen, firstly,
because it is a physiological hormone that is
indispensable for functional spermatogenesis,
and secondly, because it is a well-established
survival factor for animal germ cells (both in
vitro and in vivo) and, thus, a known physi-
ological inhibitor of testicular cell death (3, 7,
24, 56, 60, 148, 155, 157, 285).
As expected, testosterone inhibited human male
germ cell apoptosis (Table 3; Fig.5; Paper I,
Fig.2; Paper II, Fig. 1). Therefore, testosterone
is an important regulator of germ cell apoptosis
not only in animals, but also in the human tes-
tis. Somewhat surprisingly, the death-suppress-
ing effects of testosterone did not show a dose-
dependent pattern. Rather, it appeared that 10-
7M was the most effective concentration, higher
or lower ones being less antiapoptotic. Inter-
estingly, the most effective concentration is
closest to the physiological one (286, 287). Even
though the reasons for this unusual dose re-
sponse remain unclear and the possible role of
testosterone as an inducer of apoptosis in some
of the stages cannot be ruled out, it seems rea-
sonable to suppose that the physiological con-
centration is the most powerful suppressor of
germ cell death. Furthermore, this type of dose
dependence suggests that the culture model is
close to the physiological situation. This has
been further confirmed in a later investigation
by our study group, in which estradiol, another
physiological steroid hormone, was demon-
strated to exhibit a similar dose response, i.e.
the physiological concentration of estradiol was
the most effective in suppressing germ cell
death (166). Moreover, physiological concen-
trations of lactate inhibited germ cell apoptosis
in the present model (Paper V; see below).
The mechanism underlying the role of testoster-
one as a germ cell survival factor is unclear. Most
studies suggest that androgen receptors (ARs)
are expressed only by the Sertoli cells, which
indicates that the effects of testosterone on
germ cells take place indirectly (8, 23, 59, 60).
Such indirect mechanisms could, for instance,
include modulation of the production of
paracrine or direct cell contact survival factors
in Sertoli cells (Fig.5). However, testosterone
may also exert a direct action on germ cells, since
occasional investigations have suggested the
expression of ARs by the germ cells (61-64). In
addition to the fact that the target cells of the
action of testosterone remain to be confirmed,
the intracellular effects of this hormone are un-
determined. As oxidative systems have been
associated with changes in hormonal support,
alterations in antioxidative homeostasis may
contribute to the effect of testosterone (87, 96,
111, 114-118, 120, 252). The anti-apoptotic ac-
tion of androgens may also involve the Bcl-2
family members, since, for example, germ cell
apoptosis induced by testosterone withdrawal
resulted in changes in the levels of Bcl-w, Bax,
and Bak (204), and, after long-term anti-andro-
gen treatment, Bcl-xL and Bcl-2 expressions in
the testis were altered (23, 285). This last effect
may not be physiologically important, however,
since the expressions of the Bcl-xL and Bcl-2
proteins were not altered during the initial
phases of anti-androgen treatment, when
apoptosis was maximal. Furthermore, even
though testosterone withdrawal is associated
with changes in the expression of Bcl-w, treat-
ment with testosterone did not affect its expres-
sion in rat seminiferous tubules (204). In terms
of other potential mechanisms of the action of
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testosterone, it is possible that some of the tes-
ticular metabolites of testosterone, such as
dihydrotestosterone (DHT) or estrogens, could
at least partly be responsible for its pro-sur-
vival effects. In this respect, our study group
has recently demonstrated that estradiol seems
to be an even more potent inhibitor of testicular
germ cell apoptosis in vitro than the androgens
testosterone or DHT (166). However, the final
targets of steroid hormone action remain to be
clarified, since the cellular targets of estrogens
are also unclear.
9.3 N-ACETYL-L-CYSTEINE
(NAC) INHIBITS MALE
GERM CELL APOPTOSIS
In the present in vitro model, hormonal with-
drawal appears to be involved in the induction
of germ cell death. As steroid hormones and
their withdrawal have been suggested to take
part in the modulation of antioxidative defenses
(87, 96, 111, 114-118, 120, 252), we wished to
find out whether these systems are involved in
testicular apoptosis, and therefore tested the
ability of NAC to modulate germ cell death. NAC
was chosen as a potential effector of testicular
cell death for several reasons. (i) It is an effec-
tive antioxidant and a precursor of GSH, which
is known to play an important role in testicular
oxidative systems, and which, in several cell
types, has been said to be depleted during the
death processes (69, 88, 101, 102, 108, 248). (ii)
Ovarian cell apoptosis induced by deprivation
of hormone support has been shown to be pre-
vented by inhibitors of oxidative stress, includ-
ing NAC (116). Even though the reproductive
systems of the different genders differ from each
other, there are various cellular functions that
share similar characters in male and female sys-
tems, and therefore we aimed at characterizing
whether NAC would also be a survival factor in
male gonads. (iii) As future visions include in
vivo treatments for inappropriate germ cell death,
we chose a non-toxic compound for which there
is extensive clinical experience (88, 102, 288, 289),
and which has been suggested to be a potential
therapeutic factor for male infertility (254).
In the present in vitro culture model, NAC, at
concentrations of 50-125 mM, inhibited male
germ cell apoptosis effectively and dose-depen-
dently (Table 3; Fig.5; Paper II, Fig. 1). There-
fore, oxidative mechanisms may play a role in
human testicular apoptotic pathways that are,
at least partly, triggered by withdrawal of hor-
mones. However, the exact mechanisms under-
lying the death-suppressing action of NAC re-
main to be further clarified, since the redox sta-
tus was not directly determined. Notably, there
is a possibility that the effects of NAC are not
related to its antioxidative functions or are mul-
tiple, since NAC has several other potential tar-
gets of action, besides the oxidative systems. It
has been described to protect cells via mecha-
nisms that are related to its nucleophilicity, vari-
ous effects on metabolism (e.g. on sphingolipid
metabolism), mitochondria (e.g. inhibition of PT),
DNA repair, cell transformation, gene expres-
sion, and signal transduction pathways, etc (88,
101, 134). In addition, using high concentrations
of NAC (such as 125 mM) results in changes in
osmotic pressures, which in turn may play a
role in its effects on cell death mechanisms.
Thus, the causalities of hormonal action and
oxidative systems remain to be further evalu-
ated.
In contrast to testosterone, which was antiapop-
totic only in short-term cultures(Table3;Paper I,
Fig2;Paper II, Fig1) NAC maintained its efficacy
results and discussion
48
as a pro-survival factor even in culture for 48
(Paper II) and 72 (data not shown) hours. This
may reflect several possibilities (Fig.5). Firstly,
in the present model, there may be more than
one trigger of apoptosis, and, therefore, several
parallel apoptotic cascades (some of which may
be activated only after longer incubations).
Thus, testosterone may act in only one (or
some) of these pathways, whereas NAC may
affect many or most of them (Fig.5). Alterna-
tively, the different cascades may have late steps
in common, which are regulated by NAC. Sec-
ondly, NAC (or its metabolites) may interact with
systems that are essential for apoptosis, irre-
spective of its inductor. Finally, testosterone
may require further metabolism, which may be
disturbed in longer incubations, thus prevent-
ing the action of testosterone on cell death.
Irrespective of the mechanism of its action, NAC
is definitely a significant survival factor in hu-
man male germ cells. Thus, it appears to be an
effective modulator of cell death in both female
and male gonads, perhaps indicating that the
intracellular targets of NAC are conserved in
these organs. In terms of mature (adult) sper-
matogenesis, NAC may affect sperm quality at
several levels, i.e. at the testicular level (”up-
stream sperm”) by improving the production of
spermatozoa via inhibition of the inappropriate
death of their precursors, and at the level of
sperm by decreasing high levels of ROS (254).
Thus, the present findings support the previ-
ous suggestion that NAC may offer a new thera-
peutic possibility, at least in a subgroup of men
with oligospermia (254).
9.4 PARTIAL OXYGEN
PRESSURE AFFECTS
MALE GERM CELL
APOPTOSIS
The results obtained with NAC indicate the
possible involvement of oxidative conditions
and ROS in testicular apoptosis. As mitochon-
dria are the main production site of ROS and as
oxygen is the main substrate of ROS, we next
evaluated the role of oxygen tension in germ
cell apoptosis (83, 87, 88). Furthermore, the ef-
fects of relative hyperoxia, which can modulate
the apoptotic pathways of the control cultures,
were studied by lowering the partial oxygen pres-
sure. Finally, as mitochondrial functions, includ-
ing the control of oxidative conditions, are
known to play a crucial role in controlling cell
death in various non-testicular cells, it was of
interest to investigate their hitherto unknown
role in human testicular cells (17, 69, 87, 88, 96,
195, 200, 246, 248).
In the present study, germ cell apoptosis was
suppressed in an inversely dose-dependent
fashion at partial oxygen pressures of 5, 2 and
0.5% O2 (Paper III, Fig. 1). Even though lower-
ing of the oxygen tension results in diminished
production of ROS and, thus, provides indirect
evidence of the possible role of ROS, it also has
other consequences, such as reducing the mi-
tochondrial generation of ATP. Therefore, the
present findings indicate an association in be-
tween ROS and testicular cell death, but do not
show causalities. Nevertheless, these findings
clearly demonstrate that human germ cell
apoptosis, which is triggered by the present
culture conditions, involves oxygen-dependent
step(s) (Table 3, Fig.5). Furthermore, in addition
to withdrawal of survival factors (i.e. serum and
hormones), induction of germ cell apoptosis in
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the present model appears to include relative
hyperoxia. The prevention of cell death by (rela-
tive) hypoxia is consistent, for instance, with
neuronal cells and thymocytes (246, 290),
whereas, for example, in cardiac myocytes, and
in hepatoma and pheochromocytoma cells, hy-
poxia induces cell death (291-293). Thus, the
role of oxygen in controlling cell death appears
to depend on the cell type and the inducer of
apoptosis, as seems to be the case with most of
the regulators of apoptosis.
9.5 INHIBITION OF PER-
MEABILITY TRANSITION
PREVENTS MALE GERM
CELL DEATH
The apoptotic cells of the control cultures (i.e.
given no treatments) exhibited signs of alter-
ations in mitochondrial morphology. Under the
electron microscope, the mitochondria of these
cells appeared enlarged and swollen, and some
of the membranes were discontinuous (Paper
III, Fig. 4). These structural changes seem not
to be the result of unspecific swelling or arti-
facts of fixation, since the mitochondria of the
very neighboring cells (if not apoptotic) showed
normal morphology. The mechanisms underly-
ing the mitochondrial alterations, which occur
in some cell types but do not necessarily take
place in all the cell types, are poorly understood
(69, 198, 294-297). One proposed explanation
suggests that mitochondrial permeability tran-
sition (PT) could, in addition to its other conse-
quences, result in morphological changes in the
mitochondria (69, 198). Therefore, the next aim
was to evaluate whether PT was involved in the
regulation of human male germ cell death.
In the present study, cyclosporin A (CsA) and
N-methyl-Val4-Csa were used to prevent PT. CsA
binds to mitochondrial cyclophilin D, which is
one of the components of a mitochondrial
multiprotein pore complex (17, 126, 132, 134, 193,
195). This pore complex has been suggested to
be responsible for PT, which can thus be pre-
vented by CsA. As CsA, in addition to its mito-
chondrial effects, has an immunosuppressive
role, the ability of its non-immunosuppressive
derivative N-methyl-Val4-Csa (which also inhib-
its PT) to suppress germ cell death was investi-
gated. As expected, in vitro induced testicular
apoptosis was suppressed, effectively and
dose-dependently, by CsA (Paper III, Fig. 2).
Therefore, the apoptotic cascades of human
male germ cells seem to include mitochondrial
PT-related steps (Table 3, Fig.5.). This was fur-
ther confirmed, and the immunosuppressive role
of CsA as a possible regulator of death path-
ways was excluded, by the finding of inhibition
of testicular apoptosis by N-methyl-Val4-Csa
(Paper III, Fig 2).
9.6 DECLINE IN THE LEV-
ELS OF ADENINE NUCLE-
OTIDES (ANs; ATP, ADP
AND AMP) DURING CUL-
TURE
The findings showing suppression of germ cell
apoptosis by (relative) gas hypoxia may indi-
cate a role for ATP production in the regulation
of cell death. Indeed, there are various studies
describing ATP as an important, although con-
tradictory, modulator of cell death (16, 69, 202,
220, 236). Interestingly, there appears to be regu-
lation in the opposite direction, for the apoptotic
process itself seems to change the levels of ATP
(and other ANs) (69, 194, 196, 202, 218-224). The
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Fig.4. The effects of in vitro induction of apoptosis, and of  its inhibition by chemical anoxia or lactate,
on adenine nucleotide levels in human testicular tissue. Segments of human seminiferous tubules were
cultured under serum-free conditions in relative hyperoxia. Apoptosis was detected by Southern blot analysis
of DNA fragmentation (low-molecular-weight DNA; <1.3 kb), and the levels of adenine nucleotides (ANs,
ATP, ADP and AMP) were determined by HPLC, as described in "Materials and methods”. A. Incubation for
4 h and 24 h under serum-free culture conditions in relative hyperoxia induced a time-dependent increase in
apoptotic laddering, and concomitantly decreased the levels of all the ANs. B. Chemical anoxia was induced
by potassium cyanide (KCN, 10mM), which inhibits mitochondrial respiration, and 2-deoxyglucose (2-DG,
10mM), an antimetabolite of cytosolic glycolysis. After 4 h of culture, chemical anoxia (KCN+/-2-DG)
effectively suppressed testicular apoptosis, whereas after 24 h of incubation, an increase in DNA fragmenta-
tion indicating delayed apoptosis was observed. As compared with the control cultures, exposure to KCN (+/
-2-DG) further decreased the testicular ATP levels, which were mostly totally depleted. C. Segments of
seminiferous tubules were cultured in the absence or presence of lactate (10mM) or extra pyruvate (5mM),
which are substrates for germ cell ATP production. After 4 h of culture, lactate effectively inhibited testicular
cell apoptosis, whereas extra pyruvate did not mimic this effect of lactate. Interestingly, no significant
differences in ATP, ADP, or AMP concentrations were observed between the control (Contr.) samples and
the samples treated with lactate (Lac.) or with extra pyruvate (Pyr.), thus suggesting that the antiapoptotic
role of lactate is not explained by its action on the level(s) of ATP (or other ANs).
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effects of apoptotic events on the AN levels in
testicular cells are unknown. Therefore, prior to
evaluating the role of ATP generation as a pos-
sible regulator of apoptosis, our aim was to char-
acterize the changes in the levels of ATP, ADP,
and AMP during male germ cell apoptosis.
During the present cultures, decreases in the
levels of all ANs (ATP, ADP and AMP) were
observed concomitantly with the progress of
germ cell apoptosis (Table 3; Fig.4; Paper IV, Fig
1). Prior to the cultures, the total AN levels and
the energy charges (ECs) of the human testicu-
lar samples (Fig.4; Paper IV, Fig.1) were within
the range of the levels in the testes of normal
mice (298). Even though the relatively low ECs
in the testicular tissue of humans and rodents
(298), as well as in the male glands of silkworms
(299), have been suggested to reflect a slow
blood flow and low oxygen tension in the testis
(298), no comprehensive explanations for the
relatively low ATP levels and ECs have been
offered. As the samples used for AN determi-
nations in our study were obtained from elderly
men, aging, which has been associated with a
decline in relative ATP levels and ECs (89, 300-
302), might be an additional explanatory factor
for these relatively low values. The decline in
ATP stores during the cultures, and thus dur-
ing the process of apoptosis, is in agreement
with studies in non-testicular cells, in which
apoptosis also results in a fall in ATP (218, 219).
However, there is some difference of opinion
regarding the levels of ADP, which have been
suggested to be increased as a consequence of
cell death (219). The alterations in AMP levels,
in turn, have been poorly characterized.
The mechanism underlying the alterations in
adenine nucleotides is unclear. The suppres-
sion of ATP generation has been suggested to
result from PT-induced H+-gradient collapse,
and consequent cessation of OXPHOS (126, 196,
201). This explanation for the fall in ATP could
also apply to the present model, since testicular
apoptosis appears to include PT (Fig.5). How-
ever, there are other possible explanations, such
as an increase in hydrolysis of ATP or in ATP-
consuming reactions, or substrate limitation, or
an efflux of ATP (and other ANs) from the dy-
ing cells. Furthermore, it has been proposed that
activation of cell death cascades would lead to
perturbation of mitochondrial ATP/ADP ex-
change and thereafter to a decreased rate of
OXPHOS (219). This defect, suggested to pre-
cede other mitochondrial deficiencies, such as
PT, has been associated with a decline in ATP
levels and an increase in cytoplasmic ADP lev-
els (219). The present decrease in ADP and AMP
levels, in conjugation with the levels of ATP, is
not necessarily inconsistent with the findings
concerning the defect in mitochondrial ATP/
ADP exchange. Firstly, we measured total ADP
instead of cytoplasmic ADP, and thus, although
it seems unlikely, an increase in cytoplasmic
ADP together with a decrease in some other
cellular compartment cannot be excluded. Sec-
ondly, the testicular cells of the present study
may exhibit a more profound compromise in
energy status, which, in turn, would explain the
decrease in AN levels. Thus, because of the
significant fall in the levels of all ANs, it is pos-
sible that degradation of ANs would be en-
hanced during the cultures, and that the miss-
ing pool could be found in their degradation
products such as adenosine, inosine, hypoxan-
thine, xanthine, and uric acid (303). Neverthe-
less, even though the mechanism remains un-
clear, the present findings clearly demonstrate
that in vitro incubation of testis tissue results
in induction of germ cell apoptosis, which is
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associated with declines in testicular ATP, ADP,
and AMP levels (Table 3; Fig.4).
9.7 CHEMICAL ANOXIA
DELAYS MALE GERM
CELL APOPTOSIS
As ATP generation may control cell death cas-
cades, we next aimed at further investigation of
the role of ATP in testicular apoptosis. (16, 69,
202, 220, 225-240). Lowering of the oxygen ten-
sion results not only in suppression of mito-
chondrial ATP production, but also in concomi-
tant reduction in the generation of ROS. Thus,
either (or both) of these could be responsible
for the antiapoptotic effects of low partial oxy-
gen pressures. Therefore, the aim was to create
conditions that would reduce the generation of
either ATP or ROS or, preferentially, suppress
the level of one and increase that of the other.
According to the literature, potassium cyanide
(KCN) is a compound that could produce such
conditions. Cyanide induces chemical anoxia,
i.e. blocks mitochondrial respiration (OXPHOS),
by inhibiting cytochrome c oxidase (mitochon-
drial complex IV) (66, 69), and, thus, prevents
mitochondrial ATP production. Furthermore, in
contrast to gas anoxia/hypoxia, it increases ROS
generation (304, 305). As with other modulators
of ATP production, the effects of cyanide on
cell death have been controversial. In non-tes-
ticular cells, cyanide may induce, inhibit, or de-
lay apoptosis, or switch the type of cell death
from apoptosis to necrosis, irrespective of its
concentration (227, 236, 283, 284, 304, 306). In
the testis, its role in the regulation of apoptosis
was completely unknown.
Interestingly, KCN generally led to total deple-
tion of the levels of ATP (while lowering the
levels of other ANs) and simultaneously effec-
tively inhibited apoptotic DNA laddering after
4 hours of culture (Fig.4; Table 3; Paper IV, Fig
2). While KCN and gas hypoxia both suppress
cell death, they concomitantly result in oppo-
site changes in the levels of ROS, i.e. hypoxia
lowers and chemical anoxia increases them (304,
305). Therefore, it somewhat surprisingly ap-
pears that ROS may not play an important role
in human testicular apoptosis. If this is the case,
the effects of NAC should also be explained by
its action on factors other than ROS. However,
that ROS could act as significant regulators of
germ cell death is not totally excluded. This is
possible if the action of ROS takes place up-
stream of the effects of KCN. Thus, even if ROS
participated in the cell death pathways, the
progress along these pathways to the final ex-
ecution steps could be inhibited by KCN (Fig.5).
Furthermore, exposure to KCN induced morpho-
logical changes (detected by EM) in individual
cells, indicating cell death (Paper IV, Figs. 4-5).
These changes may be mediated, at least partly,
by ROS. That these alterations in sporadic cells
did not affect the results obtained by Southern
blot analysis or ISEL, is explained by the fact
that, to observe the changes by these methods,
a relatively large number of changed cells is
needed.
That KCN depleted the ATP levels and inhib-
ited apoptosis may indicate an important role
for ATP in the regulation of the primary cell death
cascades of male germ cells. However, KCN only
blocks ATP production via mitochondrial res-
piration, and thus there is a possibility for cyto-
solic ATP generation. Therefore, 2-
deoxyglucose (2-DG), an inhibitor of glycoly-
sis, was also added to the cultures (68). Inter-
estingly, neither the antiapoptotic effects of
KCN nor the AN levels were affected by addi-
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tion of 2-DG (Fig.4; Paper IV, Fig 2), and 2-DG
by itself did not inhibit testicular apoptosis
(Table 3). Thus, there are (at least) two possi-
bilities. First, ATP as such may indeed control
testicular apoptosis (i.e. KCN alone is efficient
enough to suppress ATP production). Second,
as the death-suppressing effect of KCN was
observed in a situation in which some ATP pro-
duction may occur via glycolysis, it is possible
that the antiapoptotic role of KCN is not medi-
ated via ATP per se, but rather via some other
targets of KCN action. Exposure to KCN pre-
vents the formation and maintenance of the mi-
tochondrial membrane potential, which, in turn,
results in cessation of ATP production by
OXPHOS. Thus, it is possible that the mitochon-
drial membrane potential as such plays an im-
portant role in controlling germ cell death, the
fall in ATP being merely a simultaneous, but
non-regulative, event. The mitochondrial mem-
brane potential could, for example, be required
for opening the mitochondrial PT pores, which
in turn appear to regulate testicular cell death.
Other targets of action could, for example, be
the effects of KCN on cytochrome c release or
changes in the redox states of pyridine nucle-
otides [NAD(P)H] (which are both likely to be
related to PT), or on the levels of other ANs
(because they were also decreased in the KCN-
treated samples) or even on some non-mito-
chondrial events. Therefore, the exact site(s) of
the antiapoptotic action of KCN and also the
exact role of ATP in the present model remain to
be further clarified.
Despite partial inhibition of cell death in long-
term (24 hours) cultures, exposure to KCN (+/-
2-DG) resulted in some DNA fragmentation, in-
dicating apoptotic cell death (Fig.4.; Paper IV,
Fig 2). Thus, chemical anoxia (+/- inhibition of
glycolysis) instead, for example, of driving all
the testicular cells to necrosis, delayed
apoptosis in many of the cells. That the cells
underwent apoptosis despite severe ATP deple-
tion can be explained in several ways. Firstly,
since the ANs were measured at the level of the
tissue rather than that of specific cells, it is pos-
sible that individual cells may have had ATP
levels that were too low to be detected in HPLC,
although high enough for the apoptotic pro-
cess. However, we regard this as unlikely, since
exposure to H2O2 induced testicular necrosis,
even though the ATP levels did not differ sig-
nificantly from those in the samples treated with
KCN (+/- 2-DG). Secondly, as already stated,
the antiapoptotic effect of KCN, and therefore
also a delay in cell death, may have been medi-
ated by a mechanism that is not explained by
the ATP levels. Thirdly, the pyruvate in the cul-
ture medium may have affected the results, be-
cause pyruvate has been found to oppose the
effects of cyanide (236, 307). Therefore, experi-
ments aimed at investigating whether pyruvate
could subdue the effects of KCN were per-
formed. However, pyruvate appeared not to ex-
plain the results. To alter the effects of KCN on
testicular cell death, a very high concentration
of extra pyruvate (50 mM) was required (and,
even then, the effect was not significant). Fi-
nally, longer incubations may have induced ac-
tivation of secondary apoptotic pathways that
do not require ATP or functional mitochondrial
respiration. Whatever the explanation, our find-
ings clearly show that KCN-mediated inhibition
of mitochondrial respiration (OXPHOS) plays
an important role in controlling the primary cell
death cascades in most of the testicular cells,
and that at least some testicular cells die by
delayed apoptosis despite KCN treatment, thus
indicating activation of secondary pathways
which do not require functional OXPHOS
(Fig.5).
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Fig. 4. Mitochondrial-related steps in human male germ cell apoptosis. Male germ cell apoptosis is
triggered by incubating segments of seminiferous tubules under culture conditions that include withdrawal of
serum and hormones, and relative hyperoxia. The primary apoptotic process appears to take place via the
mitochondrial pathway. Germ cell death is inhibited by a thiol antioxidant, NAC, and low oxygen tensions
(O2 ), suggesting a role for oxidative conditions in controlling apoptosis. Involvement of mitochondrial
permeability transition (PT) is indicated by mitochondrial swelling and by the abilities of cyclosporin A
(CsA) and N-methyl-Val4-CsA (NMV-CsA) to suppress apoptosis. PT, followed by dissipation of the
transmembrane potential (∆ψm) and consequent cessation of ATP production by OXPHOS, may (at least
partly) explain the decrease in the ATP levels. Factor(s) related to mitochondrial respiration appear to be
crucial regulators of apoptosis, since (relative) hypoxia (O2 ) and chemical anoxia (KCN) inhibit cell death,
whereas blockade of cytosolic glycolysis has no effect on germ cell death. However, lactate, which is a
physiological substrate of male germ cell ATP generation, appears not to mediate its antiapoptotic effect via
the levels of ATP. In the seminiferous tubules containing several interacting cells, the final site of the death-
suppressing action of lactate, NAC, and KCN, seems to take place in germ cells downstream of the Fas
receptor activation. However, that these compounds, as well as testosterone, would primarily act e.g. on the
Sertoli cells is not totally excluded, as they could induce in Sertoli cells the production of antiapoptotic
factors, which in turn would act on germ cells downstream of the Fas receptors. In addition to the mitochon-
drial pathway, the apoptotic cascades of the germ cells may take place via secondary activation of the non-
mitochondrial pathway, because despite most treatments which prevent mitochondrial events, apoptosis is
induced during long-term culture.
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9.8 LACTATE SUP-
PRESSES MALE GERM
CELL APOPTOSIS
As mitochondrial respiration appeared to take
part in the regulation of testicular apoptosis,
the next aim was to examine its role from differ-
ent a point of view. The objective was to evalu-
ate whether addition of a substrate of OXPHOS,
and thus its stimulation rather than suppres-
sion (which was mediated by hypoxia and KCN),
would affect cell death. Thus, the effect of lac-
tate as a possible regulator of germ cell death
was investigated. Lactate was chosen because
it is a preferential substrate of OXPHOS in those
cell types that are mainly undergoing apoptosis
in the present culture model, i.e. in spermatids
and spermatocytes (70-74). Furthermore, the
decision to study the role of lactate was based
on two other grounds. Firstly, since the levels
of ATP (and other ANs) were found to decrease
even in the control cultures, it was of interest to
investigate whether lactate, a primary substrate
for ATP generation in the germ cells, would be
involved in the control of cell death. Secondly,
deprivation of lactate has been shown to de-
crease the viability of male germ cells in vitro
(70) and, moreover, treatment with lactate is
known to suppress germ cell loss and improve
spermatogenesis in the cryptorchid rat testis in
vivo (274). Thus, since lactate appears to act as
a testicular survival factor in rodents, it was of
interest to study its effects in human tissue.
In the present study, physiological (and higher)
concentrations of lactate effectively suppressed
human male germ cell apoptosis after 4 hours of
culture (Fig.4; Paper V, Fig 1). However, in the
present as well as in the in vivo study on rats,
loss of germ cells continued after a delay, de-
spite the lactate treatment (274). This cessation
of the efficiency of lactate may indicate activa-
tion of secondary apoptotic pathways that are
not controlled by lactate (Fig.5). In the rat study,
the delay lasted for days, whereas, in our study
on human cells, clear DNA laddering indicating
cell death was observed after 24 hours (Paper V,
Fig 1). These different time courses may either
reflect species-specific differences in the sensi-
tivity of the germ cells to apoptosis, or may have
resulted from the different death-inducing
stimuli. Nevertheless, both these studies, as well
as the study showing decreased viability of male
germ cells as a consequence of pharmacologi-
cal deprivation of lactate, clearly suggest that
lactate plays an important role in the control of
germ cell death in both rodents and humans
(70, 274).
Interestingly, no significant differences in ATP,
ADP or AMP concentrations (detected by
HPLC; Fig. 4) or in ATP/ADP proportions or
adenylate energy charges were observed be-
tween the samples treated with lactate and the
control samples (Table 3; Fig. 4). Thus, the
antiapoptotic effect of lactate appears to be
mediated by a mechanism that is not explained
by changes in the AN levels. This view is fur-
ther supported by the finding that addition of
extra pyruvate (a metabolite of lactate, and a
substrate for OXPHOS) neither inhibited
apoptosis nor affected the levels of ANs (Table
3; Fig.4. Paper V, Fig. 1). These findings also
suggest that, in the present conditions, high
concentrations of exogenous lactate did not
support the further use of pyruvate as an en-
ergy-yielding substrate. Moreover, experiments
were conducted in which OXPHOS was blocked
at the level of either complex I (by using roten-
one) or complex IV (by using KCN). That the
effect of lactate on testicular cell death was not
modified by these compounds may also indi-
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cate a non-mitochondrial role for lactate. How-
ever, KCN (Fig.4; Paper IV, Fig. 2) and rotenone
(data not shown) both inhibited apoptosis, and
thus, their possible ability to subdue the
antiapoptotic effect of lactate may be hidden
by their own ability to suppress cell death.
Nevertheless, from the results showing no sig-
nificant differences in the levels of ATP (and
other ANs) between the controls and the
samples treated with lactate or extra pyruvate
(Fig.4), it can also be inferred that the fall in
ATP levels during the control cultures (i.e. 0 h
vs 4 h control; Fig.4; Paper IV, Fig. 1) does not
seem to reflect inadequate amounts of substrates
for OXPHOS in the medium. However, this is
not totally excluded, as there is a possibility,
even though an unlikely one, that the cellular
intake of lactate or pyruvate was disturbed in
the culture conditions. Furthermore, the AN
levels were measured after culture for 4 hours
(the timepoint for effective inhibition of
apoptosis by lactate), and the possibility that
lactate or extra pyruvate might have altered the
AN levels at some other time point cannot be
excluded. Since the ANs of specific cell types
were not measured, changes in individual cells
cannot be ruled out either. The inability of lac-
tate and extra pyruvate to enhance ATP pro-
duction may reflect impaired function of
OXPHOS mediated by apoptotic events, such
as PT. Thus, because of the disturbed function
of OXPHOS, addition of the substrates cannot
have effects on ATP generation. Moreover, such
occurrences as leakage of ATP (and other ANs)
from the dying cells or its (their) extensive deg-
radation may explain the fall in ATP, which can-
not be compensated by enhanced production.
The mechanism by which lactate prevented
germ cell death remained unclear. The previously
reported antiapoptotic effects of pyruvate have
been suggested to be mediated via its antioxi-
dant capacity or via products of its metabolism
in the mitochondrial matrix compartment (308,
309). But since, in the present study, even high
concentrations of pyruvate had no effect on
testicular cell death, it is unlikely that these
mechanisms played a role in the present find-
ings. In addition to its role as a substrate of
OXPHOS, lactate has several other targets of
action that may be related to its death-suppress-
ing effects. For example, lactate has been asso-
ciated with the actions of SCF, TNFα and FSH
(82, 310-312), which, in turn, have been sug-
gested to be testicular antiapoptotic factors
(140, 148, 151, 181, 204, 310, 311, 313-315). More-
over, lactate may have altered the pH levels
during the incubations, even though the pH was
adjusted prior to culture. Changes in pH levels
may affect testicular apoptosis, firstly, because
PT, which appears to regulate germ cell death,
is prevented by acidic conditions, secondly,
because expression of SCF, a germ cell survival
factor, in Sertoli cells depends on pH (312), and
thirdly, because, at least in several non-testicu-
lar cells, pH levels play a crucial role in cell death
(131, 193, 316). Furthermore, the antiapoptotic
effects of lactate, KCN, rotenone, and NAC may
be explained by changes in the redox states of
pyridine nucleotides [NAD(P)H], which are
known to be important regulators of PT and
∆Ψ
m
, and thus, of the apoptotic process (198).
However, among these and other possible
mechanisms, the one(s) explaining the death-
suppressing role of lactate (and of KCN, roten-
one, and NAC) remain to be further clarified.
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9.9 THE ANTIAPOPTOTIC
ACTIONS OF LACTATE,
NAC, AND KCN SEEM TO
TAKE PLACE DOWN-
STREAM OF FAS ACTIVA-
TION
Since cell-to-cell interactions play an important
role in germ cell survival, it is possible that lac-
tate, NAC, and/or KCN act on the Sertoli cells,
rather than on the dying germ cells, for example,
by modulating the supply of pro- or
antiapoptotic paracrine factors (Fig.5). As the
present in vitro model maintains the physiologi-
cal contacts between the different cell types,
and thus allows investigation of the paracrine
systems, the final aim of the present study was
roughly to evaluate the levels at which lactate,
KCN, and NAC exert their antiapoptotic effects.
The Fas-Fas ligand (FasL) system has been
shown to regulate germ cell death in the testis
and, importantly, also in our in vitro model (171-
176). The proapoptotic FasL expressed by the
Sertoli cells, and perhaps also by the germ cells
(173), activates the Fas receptors and conse-
quently the apoptotic cascade in the germ cells
(171, 172, 174-176). In order to evaluate whether
the antiapoptotic effects of lactate, KCN, or NAC
take place upstream or downstream of Fas re-
ceptor activation in the germ cells, we added an
agonistic anti-Fas antibody to the cultures.
Interestingly, in Southern blot analysis of DNA
fragmentation, the antiapoptotic roles of lactate,
NAC, and KCN were not modified by the acti-
vating anti-Fas antibody (Paper V, Fig.6; data
not shown). The agonistic anti-Fas antibody
by itself seemed to increase apoptosis slightly
further (Paper V, Fig.6, data not shown). How-
ever, this tendency was not significant, as was
expected, since we have previously shown that,
in the present culture conditions, the Fas sys-
tem is activated endogenously and, thus, may
already have reached close to its maximal or its
maximal rate of activation (172). Naturally, there
is a possibility that the antibody is not func-
tional in the present culture conditions, even
though it maintains its activity in non-testicular
systems. Therefore, in the primary experiments,
a recombinant human FasL protein was also
tested. As expected, the results obtained with
the use of either agonistic anti-Fas antibody or
FasL (+/- KCN) did not differ from each other
(data not shown), thus supporting the use of
the activating anti-Fas antibody in the follow-
ing studies.
That the activation of the Fas receptors did not
induce apoptosis in the presence of lactate,
NAC, or KCN, suggests that (i) these com-
pounds may inhibit the particular apoptotic path-
way that is triggered by Fas or a pathway that
has steps common in with it, and (ii) that the
inhibitory actions of the compounds take place
downstream of the Fas receptors in the germ
cells (Fig.5). However, that lactate, NAC, or KCN
may have acted primarily on the Sertoli cells is
not totally excluded. This possibility could be
explained by induction of Sertoli cell produc-
tion of antiapoptotic factor(s), which could act(s)
on germ cells downstream of the Fas receptors
(Fig.5). Whatever the primary site, the final site
of the death-suppressing action of lactate, NAC,
and KCN in the seminiferous tubules, which
contain several interacting cells, seems to be in
the germ cells downstream of the site of Fas
receptor activation.
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9.10POSSIBLE CLINICAL
USE OF NAC, (RELATIVE)
HYPOXIA, AND LACTATE
The findings obtained when using NAC, low
oxygen tensions, or lactate may have clinical
implications. NAC possibly affects sperm qual-
ity by acting at several levels, i.e. in the testis by
inhibiting germ cell death, and in the sperm by
decreasing the high levels of ROS (254). Thus,
the present findings support the suggestion that
NAC may offer a new therapeutic possibility for
some male patients with fertility problems (254).
Of the compounds used in the present study,
cyclosporin A is also widely used in clinical prac-
tice for patients with non-testicular problems.
However, since CsA, in addition to its ability to
prevent PT, has strong immunoreactive effects,
it may not be suggested (at least not in the first
line) as a compound for treating patients suffer-
ing from reproductive problems. Furthermore, its
nonimmunosuppressive derivative, N-methyl-
Val4-Csa, cannot be primarily considered either,
as there is no previous experience of its clinical
use (either for testicular or for non-testicular
problems). Low oxygen tensions and lactate, in
turn, could be used in certain in vitro fertiliza-
tion (IVF) techniques, for example in those in
which immature germ cells (spermatids) are used
for fertilizations (269, 270). The low fertilization
rates of these techniques (269, 270) may partly
result from the harmful effects of oxygen (116,
253, 317, 318), since, ex vivo, the germ cells are
usually manipulated in 21% oxygen, which is
considerably higher than the physiological oxy-
gen tension in the reproductive tract. Therefore,
in attempts to improve the success rates of vari-
ous in vitro fertilization techniques, the oxygen
levels could be lowered during germ cell manipu-
lations. Furthermore, lactate could be added to
the cultures at physiological concentrations.
9.11 FUTURE PERSPEC-
TIVES AND GENERAL DIS-
CUSSION
The long-term goals of studies on male germ
cell death are to prevent, diagnose and treat
disorders of the male reproductive health. Strat-
egies aimed at fulfilling these goals include ob-
taining information about the control of male
germ cell death and its manipulation at the cel-
lular, tissue, and in vivo level. Some of the fu-
ture (and ongoing) studies and questions raised
by the present findings include the following:
Cellular level: mechanisms related to mito-
chondrial functions. As the falls in the levels of
all the ANs, which take place concomitantly
with the process of apoptosis in the present
culture conditions, may reflect their enhanced
degradation, it will be of interest to determine
the levels of their degradation products, such
as adenosine, inosine, hypoxanthine, xanthine,
and uric acid. Furthermore, since functional mi-
tochondrial respiration appears to play an im-
portant role in the regulation of human male germ
cell death, it will be of interest in further studies
to evaluate which particular factors or mecha-
nisms are responsible for this regulatory action.
Such factors or mechanisms include possible
changes in the mitochondrial membrane poten-
tial or in the redox states of pyridine nucleotides
[NAD(P)H] during the death process and its
manipulation. Moreover, whether the inhibitors
of different complexes of the electron transport
chain and of F0F1-ATPase mimicked the effects
of KCN on germ cell death could be studied. In
addition, as KCN (+/-2-DG)-induced ATP deple-
tion inhibited the primary apoptotic pathways
of the germ cells, one of the further tasks could
involve evaluation of whether ATP per se is
essential for these pathways or whether the fall
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in ATP is just a simultaneous, but non-regula-
tive, event. In addition, among various other
factors related to mitochondrial functions and
apoptotic pathways, such substances as
ceramide (and other sphingolipids), members of
the Bcl-2 family, p53, and also pH levels, may
potentially participate in the death cascades of
human male germ cells, as they have previously
been shown to take part in the regulation of
germ cell death either in females or in male ani-
mals. Naturally, when appropriate in terms of
the study protocols, compounds and factors of
possible clinical relevance, such as atoxic fac-
tors or compounds of which there is previous
clinical experience, should be preferred.
Testicular tissue. When determining the physi-
ological and pathological functions of the tes-
tis, evaluation of the role of cellular interactions
(para/autocrine actions, structural support, etc.)
in the regulation of cell death is essential. By
using the present in vitro model, for instance,
the as yet undetermined effects of several para/
autocrine factors (such as SCF, LIF or BMFs)
and endocrine hormones on human germ cell
survival could be investigated. Furthermore,
modern gene technology enables the produc-
tion of transgenic animals with organ-specific
changes, and thus permits characterization of
the role of gene products (especially those
which, because of their action on non-testicu-
lar sites, would be lethal) in germ cell death at
the tissue level. In addition, transfections at the
tissue level (e.g. in the present model) could be
performed.
In vivo studies and treating patients suffering
from problems associated with male germ cell
death. Even after careful determination at the
cellular and/or the tissue level, there are several
aspects of the manipulation of cell death that
should be taken into account prior to conduct-
ing in vivo studies. Appropriate apoptosis is a
part of normal physiology, including functional
spermatogenesis, and it is needed for removal
of senescent or genetically damaged cells,
whose continued existence might pose harm or
even danger to the host. Therefore, the possi-
bility that external manipulation of death cas-
cades would result in suppression of appropri-
ate death, leading to unwanted effects such as
dysfunction of the organ, or induction of can-
cers, should be of concern. Furthermore, ma-
nipulation of germ cells requires special care, as
these cells are responsible for carrying genetic
information to future generations. Thus, when
fertilization is effected by cell(s) obtained from
a person with a problem in reproductive health,
undesirable characteristics, including a higher
risk of fertility problems, and certain cancers or
genetic abnormalities, may be transferred to the
offspring. In addition to in vivo treatments, this
issue concerns ex vivo techniques such as IVFs.
In view of these aspects, evaluations of both in
vivo and ex vivo treatments aimed at suppress-
ing cell death should be carried out in animals
prior to humans. As species specificity exists,
human studies will still need strict surveillance
and it will be of advantage if there is previous
clinical experience of the treatment (even in treat-
ing non-testicular disorders). Useful information
could be obtained by evaluating possible
changes in the reproductive capacity of men
receiving treatments that could be considered
therapeutically useful for treating infertility prob-
lems, but which, in these patients, have been
used for other disorders. For example, in pa-
tients receiving NAC for a non-testicular prob-
lem, sperm counts could be examined prior,
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during, and after the treatment. Furthermore, the
development of gene techniques affords new
opportunities. Studies on knockout and
transgenic animals give new insights into the
understanding of testicular patho/physiology,
and new methods of gene technology aimed at
treating even humans, raise interesting possi-
bilities as well as clinical and ethical (up to eu-
genics) questions.
9.12CONCLUSIONS
In the present study, an in vitro culture model was created for investigating the regulation of
human male germ cell death. In order to maintain cell-to-cell interactions, which play an important
role in the regulation of male germ cell death, as well as in the overall physiology and pathology of
the testis, tissue (pieces of testicular tissue or segments of seminiferous tubules) was incubated,
rather than isolated cells. The main findings obtained when using the present culture model were
the following:
1) Human male germ cell apoptosis was rapidly induced by the culture conditions, which included
withdrawal of serum and hormones, and relative hyperoxia. The cells most sensitive to these
death-inducing signals were germ cells in the later phases of differentiation, namely
spermatocytes and spermatids, but occasional spermatogonia were also observed to undergo
apoptotic death. Furthermore, of the somatic cells, sporadic Leydig cells underwent apoptosis
in the basic culture conditions, whereas Sertoli cells only underwent apoptosis after exposure
to poisonous concentrations of potassium cyanide (KCN). Types of death other than apoptosis,
in turn, were triggered by exposure to toxic concentrations of H2O2 and KCN, which induced
necrotic death and cytotoxic morphological alterations, respectively, in human male germ cells.
2) That tissue culture is a suitable model of physiological stress situations was supported by the
abilities of physiological concentrations of lactate and of testosterone, a known germ cell
survival factor, which is indispensable for functional spermatogenesis, to suppress the germ
cell apoptosis induced in vitro.
3) N-acetyl-L-cysteine (NAC), a thiol antioxidant and a precursor of glutathione, which has been
suggested as a potential therapeutic factor for male infertility, effectively inhibited male germ
cell apoptosis in the present culture conditions.
4) During the basic culture conditions, a decrease in the testicular levels of ANs (ATP, ADP, and
AMP) was observed concomitantly with the progression of the apoptotic process. One of the
potential explanations for the fall in ATP is mitochondrial permeability transition (PT), followed
by collapse of the H+ gradient, and consequent cessation of ATP generation by OXPHOS. The
involvement of PT was indicated by the alterations in mitochondrial morphology exhibited by
the dying cells, and by the abilities of two inhibitors of PT, Cyclosporin A (CsA) and N-methyl-
Val4-Csa, to suppress germ cell apoptosis effectively.
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5) Factor(s) relating to mitochondrial ATP production appeared to be crucial regulators of the
primary apoptotic cascades of male germ cell death induced in vitro, since germ cell death was
inhibited by (relative) hypoxia and chemical anoxia, whereas it was unaffected by blockade of
cytosolic glycolysis. Unexpectedly, however, lactate, which is a physiological substrate of
male germ cell energy production, did not appear to mediate its antiapoptotic effect by affecting
the levels of ATP (or other ANs).
6) In the seminiferous tubules, which contain several interacting cells, the final sites of the death-
suppressing actions of lactate, NAC, and KCN appeared to take place in germ cells downstream
of the activation of the proapoptotic Fas receptor.
7) The findings with NAC, (relative) hypoxia, and lactate may have clinical implications, in that
NAC could be considered as a possible therapeutic factor for some patients with disturbed
spermatogenesis, whereas (relative) hypoxia and lactate could be used in attempts to improve
the success rates of IVF techniques.
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